Loyola University Chicago

Loyola eCommons
Dissertations

Theses and Dissertations

1978

In Vivo and In Vitro Interactions between Bacteroides fragilis and
Escherichia coli: Their Role in Intra-Abdominal Abscess Formation
James Carl Hagen
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_diss
Part of the Microbiology Commons

Recommended Citation
Hagen, James Carl, "In Vivo and In Vitro Interactions between Bacteroides fragilis and Escherichia coli:
Their Role in Intra-Abdominal Abscess Formation" (1978). Dissertations. 1743.
https://ecommons.luc.edu/luc_diss/1743

This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons.
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1978 James Carl Hagen

IN VIVO AND IN VITRO INTERACTIONS BETWEEN
BACTEROIDES FRAGILIS AND ESCHERICHIA COLI:
THEIR ROLE IN INTRA-ABDOMINAL ABSCESS FORMATION

by
James C. Hagen

A Dissertation Submitted to the Faculty of the Graduate School
of Loyola University of Chicago in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
1978

"....

~

LO"~~~J{

~-

"j··\T1"4/r

r:

~>,

:·.__:~·~·;r-:.~·---~

ACKNOWLEDGEMENTS

TO:

Dr. T. Hashimoto, not only for the long hours and effort he has
spent to train me as a scientist and teacher, but for the kindness, understanding and extreme patience he has shown as a friend.

TO:

Drs. H. J. Blumenthal, W. S. Wood, and J. Balis for the valuable
suggestions, support, and laboratory facilities so helpful for my
studies.

TO:

Mrs. T. Hashimoto, for the great generosity and skill in preparing
figures for this dissertation as well as manuscripts and presentations in the past.

TO:

Dr. Ruth Emyanitoff, for her kind assistance in the preparation of
this dissertation, and for her many years of friendship during my
studies.

TO:

Diana Contreraz, for her typing skills and many kindnesses as a
friend.

TO:

The faculty and students of the Department of Microbiology for
their continued support and friendship.

TO:

Eli Lilly Company and Loyola (GRSG) for their financial support.

TO:

Elwin Fosedahl (Upjohn Co.) for the information and literature he
has given us •
Most importantly, to my wife and companion, Colleen, without

whose support and understanding this dissertation could never have
been completed.

Her rare ability to combine the talents of a physician

while retaining the insight of a wife have made my life during this
investigation not only bearable but truly enjoyable.
ii

LIFE
James Carl Hagen was born to Carl and Beverly Hagen in Grand
Rapids, Michigan, on March 30, 1950.

He graduated from Lowell High

School in June of 1968 and received his Bachelor of Science degree
from the Department of }tlcrobiology at Michigan State University in
June of 1972.

He began his studies in the Department of Microbiology

at the University of Montana under the guidance of Dr. J. A. Rudbach.
In December of 1973 he received his Master of Science degree with a
thesis title of "Study of the Inactivation of Endotoxin by Dogfish
Shark Serum Components," and began his Ph.D. studies at Loyola University of Chicago in January, 1974.

He is a member of Sigma Xi, the

American Society for Microbiology, and the American Association for
Dental Research, and is currently an Instructor in the Department of
Microbiology at Loyola University School of Dentistry.

iii

TABLE OF CONTENTS
Page
ACKNOWI..EDGEMENTS. • • • • • • • • • • • • • • .. • . • • • • • • • • • • • • • • • • • • • • • . • • • • • • . . •

ii

LIFE .............................................................. iii

LIST OF TABLES ..••.•.•.......•.•••....•••...•.•.................. viii
LIST OF FIGURES. . • . • . • . . • • . • . • . • • . . • . • • • . . . • . . . . • . . • . . . . . . . . . . . . .

x

LIST OF ABBREVIATIONS. • • • • • . • • • • • . . • • • • • • • • • • • • • • • • • • • • • • . • • • • • • • xii
INTRODUCTION. • • • • • • . • . • • • . . • • • • • • • • • • . • . • . • • • . • • • • • • • • . . • . • • • • • • •

1

MA.TERIALS .AN"!> METHOD. S • • • • . • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

17

I.

Isolation and maintenance of cultures ••••••••••••••••••

17

II.

Me.dia . ......••.•.•••••..• • .• · · • · · · · • · • • • • • • • · · • • · • · · · · •

18

A.
B.

c.

D.
III.
IV.

...

20

Growth

...............................
determinations. . ............................... .

20

Turbidity •••••••••
Viable counts •••••

20
20

Susceptibility of

............................. .

!· fragilis to oxygen and low tem-

perature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

A.
B.
VI.

18
19
19
19

Anaerooic system •••••••••

A.
B.
V.

Liquid media •••••••••••••
Solid media ••••••••••
Selective media ••••••
Vitamins, cofactors and supplements.

Oxygen tolerance.
Cold tolerance •••

.......................... .

Interaction of B. fragilis and!· coli in vitro .•••••••

A.
B.

c.

Effect of E. coli growth on the growth of

21

21
21
23

B.. fragilis .. ............................ .

23

Effect of other organisms on B. fragilis growth..
Effect of conditioned medium on growth of

24

B. fragilis ... ........................... .

24

iv

Page
1.
2.
3.

Test in liquid medium •••••••••••••••••••••••
Test on solid media •••••••••••••••••.•••••••
Characterization of !· fragilis stimulatory factors produced by!· coli ••••••••••.•

24
24

VII.

Antibiotic susceptibility ••••••••••••••••••••••••••••.•

26

VIII.

Measurement of dissolved oxygen •••.•••••.••••••••••••••

26

IX.

Extraction of superoxide dismutase (SOD) and its
effect on B. fragilis •.....•.••..•..•....••..••...••...

27

Experimental intra-abdominal abscess formation in
rats. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

28

X.

25

A.

Animals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

28

B.
C.
D.
E.

Preparation of implants •••••••••••••••••••••••••
Rat abdominal surgery •••••••••••••••••••••••••••
Evaluation of abscess formation ••••••••••••.••••
Histologic examination of intraperitoneal
abscesses. . • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

28
29
30
30

XI.

Light microscopy and photomicrography ••••••••••••••••••

30

XII.

Analysis of data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

31

RESULTS. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • . • • • • • • • • • • • • • • • • •

32

I.

Characterization of B. fragilis used in this
investigation ......................................... .

A.
B.
C.

32
32

D.

Growth of B. fragilis in enriched TSB ••••.••••••
Antibiotic susceptibility of B. fragilis ••••••••
Survival of !· fragilis after storage in
atmospheric oxygen. • • • • • • • • • • • • • . • • • • • • • • • • • • • • •
Survival of B. fragilis after storage at low
temperature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

35

E.

Survival of

35

!· fragilis in experimentally

produced pus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

40

Preliminary animal experiments •••••••..•••••••••

44

1.
2.
3.

Inoculation of bacterial suspensions •.••••••
Implantation of rat fecal material ••••••••.•
Implantation of bacteria impregnated in
"artificial feces" .•••••.••••••••••••.•••••.

48
48

Interactions between B. fragilis and E. coli in vivo •••

50

F.

II.

32

v

50

Page
A.

Enhancement of _l!. fragilis pathogenicity by

B.

Lethality of B. fragilis and !· coli for

the rat.........................................

54

C.
D.

Histology of experimentally produced abscesses ••
Factors affecting intraperitoneal abscess
formation caused by _l!. fragilis .••••••••••••.••.

55

E. coli.........................................

1.

57

Effect of suspending material on abscess

formation...................................
III.

57

Effect of inoculum size on abscess
formation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.

50

60

Effect of!· coli on the growth of B. fragilis in
vitro. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

A.

Growth of B. fragilis and E. coli in peptone
media •••••••
1.

2.
3.

4.
5.
6.

Enhancement of _l!. fragilis growth in the
presence of!· coli •••••••••••••••••••••••••
Suitability of various peptone media for
studying the in vitro interaction between
_l!. fragilis and!·~·····················
Enhancement of B. fragilis growth by E.
coli while separated by a dialysis membrane.
Effect of selective inhibition of E. coli
growth on the survival and growth -of
!· fragilis in mixed culture ••••••••••••••••
Effect of inoculum size of E. coli on
growth of!· fragilis in mixed~ture ••••••
Mechanisms of the enhancement of !· fragilis
growth by!· coli in Bacto-peptone medium •••

63

63

65
65

--

a.
b.

69

71
71

Dissolved oxygen ••••••••••••••••••••••••
Removal of toxic superoxide radicals
or other growth inhibitors ••••••••••••••
E. coli production of nutrients or vitamins that stimulate the growth of
!· fragilis.............................

77

Interaction of !· fragilis and !• coli when
grown in mixed culture in semi-synthetic medium.

80

c.

B.

63

1.

2.

Kinetic studies of enhancement of B.
fragilis growth by !· coli. .•••.•••••••••..•
Enhancement of !· fragilis growth in mixed
culture after inhibition of E. coli by
kanamycin . ................................. .

vi

73
77

83
83

Page
Demonstration of the !· fragilis growth
stimulatory activity of E. coli spent
media by the plate agar diffusion method ••.•

87

Some properties of the !· fragilis growth
stimulatory factor(s) produced by!· coli •••.•••

87

DISCUSSION. . . • . . . • • . . . . . . • • • • . . . . . . . . • • . . . . . . . . • . • • . • • . • • • • . . • . . .

92

3.

C.

I.

Susceptibility of

!· fragilis and E. coli to oxygen

and low temperature... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

II.

In vivo and in vitro interaction of

!· fragilis and

E. coli................................................
S~Y.

92

95

. . . . . • . . . . . . . . • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . . . . . . . . 114

LITERATtJRE CITED. . . . . • • . . • • . . • . . . . . . . • • • • • . • . .. . . • • . . . . . . • . . • . . . . . 116

vii

LIST OF TABLES
Table

Page
for~·

1.

MIC of various antibiotics

fragilis and!· coli •.•..

34

2.

Effect of selected compounds on the survival of~·
fragilis at 4 °C in enriched TSB. . . . . . . • . . • . . . • • • • . . . . . . . • . .

43

3.

4.
5.

6.

7.
8.

Change in viable cell number of

_g.

~·

fragilis and

coli in pus at l5°C .... ~................................

47

Average weight and bacteriological data of abscesses
experimentally produced in rats .••••••.•••••••••.••••••••••

51

Average weight of abscesses experimentally produced in
rats by B. fragilis........................................

58

Average weight of abscesses experimentally produced in
rats by E. coli. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

59

Average weight of abscesses caused by low numbers of B.
fragilis and E. coli.......................................

61

Growth of

~·

fragilis and oxygen levels in various peptone

media (5%) ................................................ .

9.

10.
11.

Growth of B. fragilis in various lots of Bacto-peptone
medium (5%) ... .•...........•....•...•..••..................

68

Growth of !· fragilis and oxygen levels in Bacto-peptone
mediuiJ1 (5io}stored under various conditions ••••••••••••.•.•

74

Enh~ncement of

!· fragilis growth by other organisms in

5% B'c to-pep tone .....•.....................................

12.

13.
14.

15.

67

76

Effect,'of-~ide dismutase on the growth of B. fra-

gilis in 5% Bacto~tone medium •.•.•••••••.••.• ~ •• ~ ••..•

78

Growth of ~· fragilis~~ stored Bacto-peptone medium
(5%) treated with activated charcoal ••.••••••••••....•..•..

79

Growth of !· fragilis in Bacto-peptone medium (lot #540620)
supplemented· with various additives .••••....•••.•••..••..••

81

Growth of ~· fragilis in stored Bacto-peptone medium supple·mented with various amounts of spent peptone medium •..••..• 82
viii

Table
16.
17.

Page
Effect of E. ££!i growth on the growth of B. fragilis in
semi-synthetic medi\Jlll......................................

86

Effect of various treatments on the!· fragilis stimulatory activity of spent semi-synthetic medium .•••••.••••••••

89

\

'

ix
------

-

LIST OF FIGURES
Page

Figure
1.
2.
3.

4.
5.

6.

Representative growth curve of

~·

fragilis in enriched

TSB at 37°C ••••••.••••.•••••••.•••••.•..•••...•............

33

Survival of B. fragilis after exposure to atmospheric
oxygen and low temperature ••••...••..•...•••••..••••...•...

36

Survival of B. fragilis after exposure to low temperature •.

38

Survival of B. fragilis after storage of fresh isolates
at low temperature . ....................................... .

39

Survival of exponentially growing and stationary phase
!· fragilis after storage at low temperature .•••••••••.••••

41

Survival of subcultured !· fragilis after storage at low
temper a ture . .............................................. .

7.
8.

Survival of!· fragilis in pus after storage at 25°C or

4 ° c . ...................................................... .

Survival of !· fragilis and !·

~

45

in pus after storage

at 25°C or 4°C .....•....•......... •.........•.............•

9.

42

46

Rats infected with B. fragilis, !· fragilis in combinatio~
or with rat fecal material ••••••.•.•••••••••• 49

with!·~'

10.
11.

Intra-abdominal abscess formed in rats by !· coli or
!· fragilis or by the combination of both organisms ..•.••••

53

Cross section of an intraperitoneal abscess formed in rats
by implantation of 108 cells of ~· fragilis cells and 106
cells of E. coli. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

56

Intra-abdominal abscess in rats caused by implantation of
blood clots impregnated with 108cells of!· fragilis ..•.••.

62

Enhancement of !· fragilis growth by !· coli, and change
in dissolved oxygen level during incubation •••.•.•..•••••..

64

Enhancement of !· fragilis growth by !· coli in Bacto-peptone (lot #630023).........................................

66

15. _Effect of !· coli growth on the growth of !· fragilis in
Bacto-peptone medium.......................................

70

---

12.
13.
14.

X

Page

Figure
16.

Effect of E. coli inoculum size on the enhancement of
fragilis growth in Bacto-peptone medium •••••••••..••..•.

72

Stimulation of~· fragilis growth by the growth of~·
coli in semi-synthetic medium •••••••••••••••••.•..•••••••..

84

Lack of inhibition of B. fragilis growth on enriched
TSA by stored peptone or semi-synthetic medium •••..•.•••••.

85

Stimulation of ~· fragilis growth by ~· coli spent peptone
and spent semi-synthetic medium ••••••••••••.••.•.•••••..•••

88

Stimulation of B. fragilis growth by spent semi-synthetic
medium subjected to various treatments •••••.••.••••..•••••.

90

~-

17.
18.
19.
20.

----

xi

ABBREVIATIONS

oc

degree centigrade

EDTA

ethylenediamine tetraacetic acid

LDso

fifty percent lethal dose

Fig.

figure

g

gram

h, hr

hour

j.lg

microgram

j.Jl

microliter

j.lm

micrometer

ml

milliliter

unn

millimeter

mM

millimolar

min

minute

M

molar

nm

nanometer

NBT

nitroblue tetrazolium

N

normal

PYG

Peptone yeast glucose

RBC

red blood cell

subsp.

subspecies

SOD

superoxide dismutase

TSA

Trypticase soy agar

TSB

Trypticase soy broth
xii

INTRODUCTION
In recent years, there has been a renewed interest in anaerobic
bacteriology and diseases caused by anaerobic organisms.

A review of

recent literature demonstrates that there has been an increase in the
isolation of such bacteria from clinical specimens.

In 1964, in a 5

hospital combined study, anaerobic bacteria were reportedly isolated
from only 2% of 1388 surgical wounds (Committee on Trauma, National
Research Council, 1964).

Bornstein et al. (1964) found that only 3%

of specimens in the clinical laboratory contained anaerobic bacteria.
In 1973, Davis et al. reported a 15% isolation rate from 7500 specimens.

Leigh (1974) studied the Bacteroides isolates during a 4 year

time period and reported a continuous increase in rate from 13% in
1970 to 83% in the first 6 months of 1974.

The increase in rate of

isolation of anaerobic bacteria, especially of

!· fragilis, has been

noted by other investigators (Gorbach and Bartlett, 1974; Altemeier
et al., 1967; Thadepalli et al., 1973; Martin, 1974; Polk and Kasper,
1977; Saksena et al., 1968).
The reported increase in isolation of anaerobic bacteria might
be due to a) an actual increase in the number of infections caused by
anaerobic bacteria, b) an apparent increase in infections because of
increased awareness of physicians as to possible presence of anaerobic
bacteria in specimens and c) more importantly, the greatly improved
techniques of anaerobic bacteriology.
Certain underlying diseases are known to predispose individuals
1

2

to infection by anaerobic bacteria.
diabetes.

These include malignancies and

With increased longevity, the incidence of these diseases

has increased considerably in recent years.

Undoubtedly, this has

contributed to an actual increase in the number of anaerobic infections and concomitant number of anaerobic species isolated.

Other

factors which might predispose to such infections include prolonged
use of corticosteroids, antimicrobial agents or antineoplastic agents.
Many investigators (Marcoux et al., 1970; Feiner and Dowell,
1971; Clark et al., 1977; Saksena et al., 1968; Finegold et al., 1970)
noted a striking number of malignancies associated with infection by
anaerobic bacteria.

Marcoux et al. (1970) found that of 123 patients

with Bacteroides bacteremia, 35 had carcinoma (21 with colon carcinoma).

In a study (Feiner and Dowell, 1971) of 250 patients with Bac-

teroides bacteremia, 57 had malignant neoplasms.

Finegold et al.

(1970) reported that 16% of 1736 patients with anaerobic infections
had malignancies.

In other studies, 25 of 174 patients (Clark et al.,

1977) and 26 of 112 patients (Saksena et al., 1968) were shown to have
underlying malignancies.

Other investigators (Chow and Guze, 1974;

Bodner et al., 1970) have also noted the prevalence of malignant neoplasms in patients with anaerobic infection indicating that malignancies might be a predisposing factor for anaerobic infections.
A second important predisposing factor is previous treatment by
antibiotics, specifically, neomycin and the other aminoglycosides.
one study (Marcoux et al., 1970), 75 of 123 patients with anaerobic
infection had prior antibiotic treatment.

Finegold et al., (1970)

noted that antibiotic therapy preceded a disproportionately large

In
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number of anaerobic infections.

These findings are supported by the

reports of others (Bodner et al., 1970; Bornstein et a1., 1964; Saksena et a1., 1968).
Diabetes (Bornstein et al., 1964; Bodner et a1., 1970; Saksena
et a1., 1968; Finegold et al., 1970; Clark et a1., 1977), corticosteroid therapy (Bodner et al., 1970; Saksena et al., 1968; Finegold
et al., 1970), organ transplants (Finegold et al., 1970), and

treatm~nt

with antineoplastic agents (Clark et al., 1977; Bornstein et al.,
1964) were also noted as being closely associated with infection by
anaerobic bacteria.

It is worth noting that in the study of Marcoux

et al. (1970) 62% of the patients had disease of the gastrointestinal
tract, and all patients were shown to have some form of underlying
disease.
Another possible reason for increased incidence of anaerobic
infection is the increased longevity of the human population.

Studies

by Ellner and Wasilauskas (1971), Sinkovics and Smith (1970) and Felner
and Dowell (1971) have also demonstrated an increased incidence of
anaerobic infection with increase in age.
The reported rise in number of anaerobic infections might also
be due to an increased awareness by the physician as to the possible
involvement of anaerobic bacteria in the disease process (Martin,
1974; DeHaan et al., 1974; Clark et al., 1977).
Infinitely more important in accounting for the apparent rise in
number of anaerobic infections are the improved techniques of anaerobic bacteriology (Leigh, 1974; Appelbaum et al., 1976; Moore et a1.,
1969; Holland et al., 1977).

The improved methods for sample collec-

4

tion, transportation and storage, isolation and identification, as well
as development of suitable culture media are jointly responsible for
higher rates of isolation of anaerobes from clinical specimens.
A major difficulty in the collection, transportation, and storage of specimens suspected of containing anaerobic bacteria has been a
loss in viability of the organisms due to their exposure to oxygen and
low temperature.

The effect of these parameters on clinically signi-

ficant anaerobic bacteria is important in determining appropriate
handling of clinical specimens.

Contrary to earlier beliefs, recent

investigations have demonstrated that clinically significant anaerobic
bacteria are quite tolerant to oxygen exposure (Bartlett et al., 1976;
Loesche, 1969; Tally et al., 1975).

In 1969, Loesche studied the

effect of differing oxygen concentrations and time of oxygen exposure
on a variety of anaerobic bacteria from stock cultures.

From the

results of this study, he classified the bacteria into two groups:
strict and aerotolerant anaerobes.

Although strict, or extremely

oxygen sensitive (EOS), anaerobes can be routinely isolated from the
normal flora by rigid anaerobic techniques, Attebery (1971) and Rosenblatt et al. (1974) failed to isolate any EOS organisms from clinical
material.

Onderdonk et al. (1974) did not isolate EOS from experi-

mental abscesses caused by rat cecal contents.

It is now relatively

•

well established that most organisms commonly isolated from anaerobic
infections are found in the moderate, or aerotolerant group of anaerobes (Bartlett et al., 1976).
late

Ueno (1968) found that he could iso-

!· fragilis from pus after as long Has one week of storage.
Since the oxygen tolerance of stock cultures may differ signifi-

cantly from that of fresh clinical isolates, Tally et al. (1975)
compared oxygen tolerance of fresh and stored cultures of

!· fragilis

and other organisms commonly associated with anaerobic infections.
They found that most clinically significant anaerobic bacteria could
tolerate exposure to oxygen for at least 8 hours and frequently for
longer periods of time.

They suggested that primary isolation and

many manipulations of anaerobic bacteria could be done on the laboratory bench in room air.
In addition to the problem of oxygen exposure, clinical specimens that cannot be processed immediately are often subjected to
storage at refrigerator temperatures.

This prevents the overgrowth

of facultative forms that occurs either aerobically or anaerobically
at room temperature.

Finegold et al. (1974) recommended that speci-

mens that could not be processed within 2 hours after collection should
be refrigerated in order to suppress the undesirable proliferation of
coexistent facultative anaerobes.

However, authors of other clinical

laboratory manuals (Dowell and Hawkins, 1974; Holdeman and Moore, 1972)
cautioned not to store specimens at low temperature because of possible detrimental effects of chilling on anaerobic bacteria.

Other

investigators have reported similar findings when certain facultative
and obligate anaerobic bacteria were suddenly exposed to low temperature (Gorrill and McNeil, 1960; Hegarty and Weeks, 1940; Strange and
Dark, 1962; Traci and Duncan, 1974).

This unresolved problem as to

the effects of low temperature needs to be further investigated.
In the past, techniques for the isolation of anaerobic bacteria
have been cumbersome, time consuming, and too expensive for routine

6

clinical use.

However, one of the major improvements in anaerobic

bacteriology has been the development of devices that make routine
anaerobic bacteriology possible.

Three devices currently in use are:

a) the anaerobe jar; b) the roll tube; c) the anaerobic chamber.
In early models of the anaerobe jar (Mcintosh and Fildes, 1916;
Stokes, 1958), atmospheric oxygen was removed by catalyzing its union
with hydrogen gas.

However, the external source of explosive hydrogen

gas posed a serious hazard.

Recently a self contained gas generating

packet has been developed (Brewer and Allgier, 1966) for production of
a hydrogen-carbon dioxide atmosphere.

The union of oxygen and hydro-

gen can be safely catalyzed, leaving a carbon dioxide atmosphere.
Finegold (1977) demonstrated that oxygen was reduced to less than 0.2%
of atmospheric levels by 1 hour using a commercially available gas
generating system (GasPak, BBL).

Since moderately oxygen sensitive

anaerobes can survive and grow under these conditions (Loesche, 1969)
and extremely oxygen sensitive anaerobes have not been recovered from
clinical specimens (Rosenblatt et al., 1974), this system is quite
effective in the isolation of anaerobic pathogens.

Due to its ease of

use and compact nature, this technique is now in use in most anaerobic
bacteriology laboratories.
The roll tube, a system in which each sample tube serves as its
own miniature anaerobic chamber, was developed and modified by Hungate
(1950), Bryant (1963) and Moore (1966).

A much higher isolation rate

of strict anaerobes can be obtained with this technique.

However, the

need for bulky tanks of gas and special media, and inherent mechanical
complexity make this technique more valuable to the researchlaboratory
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than to the clinical labs.

Lastly, anaerobic chambers have been

developed (Drasar, 1967; Aranki et al., 1969; Leach et al., 1971) in
which to perform bacteriology on clinical specimens or study the
growth and characteristics of the anaerobic bacteria (Drasar, 1967).
This technique has the advantages of providing continuous anaerobic
conditions and continuous viewing without the need of hydrogen or
catalysts, but requires a great deal of room and a large initial
expenditure.

Studies by Killgore et al., (1972) and Rosenblatt etal.,

(1974) demonstrated that all three of these methods were comparable in
their ability to recover anaerobes from clinical specimens.
Many anaerobic bacteria, including clostridia, Actinomyces, Peptococcus, Peptostreptococcus, Fusobacterium and Bacteroides have been
implicated as, or shown to be, pathogenic in man.

However, Bacteroi-

des, especially B. fragilis, was by far the most frequently isolated
anaerobic bacterium from clinical infections (Holland et al., 1977;
Lorber and Swenson, 1975; Moore et al., 1969).

!· fragilis is an

obligately anaerobic, gram negative rod which was first isolated by
Veillon and Zuber (1897).

As part of the normal flora, it makes up

95% of the colonic bacteria, outnumbering the aerobic microorganisms
by 100-1000 to 1.

Feces contains approximately 10

gram of material, the predominant species being
et al., 1974).
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Bacteroides per

!· fragilis (Finegold

The species!· fragilis has been divided into the 5

subspecies of fragilis, vulgatus, ovatus, thetaiotaomicron, and distasonis.

Subspecies thetaiotaomicron and vulgatus have been shown to

be isolated from 90-100% of fecal specimens from healthy volunteers
(Ueno et al., 1974).

In contrast, B. fragilis subsp. fragilis was
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only isolated in 30-40% of the samples, and was usually 1-2 logs lower
in concentration than the others.
As a member of the normal flora of the body,

number of roles.

!· fragilis plays a

B. fragilis in the intestinal tract is known to be a

prime producer of vitamin K for the human body (Gibbons and Engle,
1964).

It also plays a major role in the degradation of bile acids in

the gut and is vital to the proper recycling of these acids (Hill and
Drasar, 1968).

Treatment which reduces counts of Bacteroides in the

mouse intestine has been shown to render mice more susceptible to
Salmonella infections (Bohnhoff et al., 1964).

!· fragilis has been associated with infections in virtually
every part of the human body, the most commonly encountered clinical
presentation being the abscess (Gorbach and Bartlett, 1972).

Such

infections almost always arise from an endogenous source, occurring
only when the primary defense mechanisms have been breached, as in
trauma resulting from intestinal surgery, wounds (Nicholsetal., 1972;
Thadepalli et al., 1973) or the other predisposing diseases or deficiency states mentioned earlier.

These opportunistic infections are

most commonly associated with pleuropulmonary, intra-abdominal, and
female genital tract regions, as well as the bloodstream.

In an ex-

tensive study of anaerobic isolates, DeHaan et al. (1974) reported
that whenever anaerobes were isolated in the following cases, it was
Bacteroides 100% of the time from osteomyelitis cases, 89% from septicemias, 81% from intra-abdominal infections, 70% from infections of
the pelvis and genital tract, 64% from lower respiratory tract infections, and 62% from soft tissue infections.

Of 81 clinical specimens
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collected from infections of various areas of the body, 17.4% were
found to contain B. fragilis (Moore et al., 1969).

In this study, the

next most frequently isolated bacterial species was Clostridium perfringens, at 9%.

Holland et al. (1977) found that a far greater

percentage of B. fragilis (52%) was isolated from specimens collected
over a 14 year time period.
rate for B. fragilis.

Martin (1974) reported a 23% isolation

Other investigators have also demonstrated

B. fragilis to be the most frequently isolated bacteria from anaerobic
infections (Nobles, 1973; DeHaan et al., 1974).
A study of the

~·

fragilis subspecies isolated from clinical

samples revealed that subsp. fragilis was the most frequently isolated.
Holland et al. (1977) reported that 44% of the !· fragilis isolates
were subsp. fragilis, and the subsp. thetaiotaomicron was next with a
27% isolation rate.

However, as mentioned earlier, !· fragilis subsp.

fragilis is isolated much less frequently than subsp. thetaiotaomicron
and vulgatus from normal individuals.

The prevalence of infections by

subsp. fragilis when compared to the infrequency of infections by
subsp. thetaiotaomicron and subsp. vulgatus may indicate an sctive
role for!· fragilis subsp. fragilis in the pathogenic process.
Although the frequent involvement of !· fragilis in anaerobic
infections is well documented, the exact mechanisms whereby this
organism produces infection have never been completely elucidated.
There are at least three major unsolved problems concerning the infections caused by!· fragilis.

a) The ability

cause infections has never been established.

of~·

fragilis alone to

Interaction with other

microorganisms may be necessary in the pathogenesis of such infections.

10
b) Pathogenic factors in!· fragilis have never been identified.
c) Although many antibiotics and types of therapy have been used for
treatment of !· fragilis infections, results show only moderate
success.

A more effective method for the prophylaxis and chemotherapy

of B. fragilis infections needs to be developed.
It has been speculated for some time that synergistic interactions between facultative and obligate anaerobes might play an important role in the development of intra-abdominal infections (Meleney
et al., 1932; Altemeier, 1942; Hite et al., 1949; Finegold and Rosenblatt, 1973; Hill et al., 1974; Lorber and Swenson, 1975.; Stone et

al., 1975; Onderdonk et al., 1976).

However, there have only been a

few demonstrations of actual synergistic interactions between these
two types of microorganisms.

In 1932, Meleney et al. showed that

gangrenous lesions could be produced in guinea pigs by mixtures of
microaerophilic, or anaerobic, streptococci, and staphylococci, but
not by either organism alone.
Altemeier (1942) studied the bacterial isolates from 100 cases
of perforated appendix in humans, of which 96 cases contained both
aerobes and anaerobes.

He found that while pure cultures of organisms

from infections were nonpathogenic, combinations were often able to
cause progressive infections.

Hite et al. (1949) demonstrated similar

results using !· melaninogenicus, streptococci and other organisms
found as normal flora of the oral cavity.

More recently, Onderdonk et al.

(1976) reported that intra-abdominal abscesses failed to form after
implantation of Escherichia coli or !· fragilis alone into the peritoneal cavity of rats.

However, abscesses were produced in 100% of
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the animals that received the combination of these organisms, suggesting that intra-abdominal abscess formation was indeed related to
synergy between anaerobes and facultative bacteria.

However, the

nature of these interactions and the mechanisms involved are not

know~

Despite the many reports suggesting that synergistic interactions of B. fragilis and facultative anaerobes are essential for the
development of these anaerobic infections, several investigators (Hill
et al., 1974; Renz et al., 1975; Onderdonk et al., 1976; McConville
et al., 1976; Walker and Wilkins, 1976) reported

that~·

fragilis

alone could cause minute intra-abdominal abscesses in experimental
animals when bacteria were inoculated along with certain materials.
The mechanism(s) of B. fragilis pathogenicity is essentially
unknown.

~·

fragilis is not known to produce any exotoxins which

participate in the pathogenic process, although various exoenzymes,
endotoxin, and a capsule have been identified for this organism.

B.

fragilis has been found to produce a wide variety of extracellular
enzymes.

Various strains produced extracellular DNAase(Porschen and

Sonntag, 1974), phosphatase (Porschen and Spaulding, 1974), penicillinase, hyaluronidase, chondroton sulfatase, protease, and lipase
(Rudek and Hague, 1976).

Although these enzymes are thought to allow

the spread of infections caused by some facultative organisms, their
role in the pathogenic process of

~·

fragilis remains to be elucidated.

Another potentially damaging enzyme shown to be produced by B. fragilis is an extracellular heparinase (Gesner and Jenkin, 1961; Bjornson et al., 1970).

A heparinase has been hypot~esized as being

responsible for phlebitis and dissemination of anaerobic infections
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(Bjornson and Hill, 1973; Felner and Dowell, 1971; LeFrock et al.,
1976; Meyer and Finegold, 1976).

This type of thrombophlebitis has

been associated with!· fragilis septicemia (Bjornson and Hill, 1973).
However, at present, the in vivo production of a heparinase by !·
fragilis has never been demonstrated and the role of !· fragilis
heparinase in abscess formation still remains to be elucidated.
Endotoxin has been identified in!· fragilis.

However, Kasper

(1976) has shown the endotoxin of !· fragilis to be much less toxic
thari the lipopolysaccharides of Salmonella or
its novel structure.

!·

coli, possibly due to

!· fragilis lipopolysaccharides were shown to

lack both 2-keto-3 deoxyoctonate and heptose, 2 essential sugars
found in classical endotoxins (Heath et al., 1966; Osborne, 1966).

A

very loose association between polysaccharide and lipid moieties of
the lipopolysaccharide was also demonstrated.

Possibly due to these

structural characteristics, !· fragilis endotoxin could not induce two
classic examples of endotoxin toxicity, chick embryo lethality and the
localized Shwartzman reaction.

This might also account for the low

incidence of disseminated intravascular coagulation in patients with
B. fragilis sepsis, as reported by Yoshikawa et al. (1974).
Once!· fragilis bypasses the primary defense mechanisms, it
must somehow protect itself against the phagocytic defenses.

Recent

work by Kasper (1976) demonstrated that a capsule was produced by !·
fragilis subsp. fragilis but was not produced by the other subspecies.
Subsequently, Onderdonk et al. (1977) showed that capsular material
alone was able to induce abscess formation, and that encapsulated
strains of B. fragilis adhered to rat peritoneal epithelium better
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than unencapsulated strains (Onderdonk et al., 1978).

This might

explain the increased frequency of isolation of subspecies fragilis
when compared to the other subspecies.

However, contrary to these

findings, Babb and Cummins (1978) demonstrated that three of the other
~·

fragilis subspecies, vulgatus, thetaiotaomicron, and ovatus, also

possessed capsules and cautioned that capsules may not be a unique
pathogenic factor of subsp. fragilis.
The third main question concerns the selection of proper and
effective antibiotics for chemotherapy of anaerobic infections.

The

confusion arises from the question as to which organisms antibiotic
therapy should be directed in mixed bacterial infections.

Polk

(1977) infers that only the facultative component of such infection
needs to be treated.

He found that a failure to treat surgical infec-

tions of the large intestine with cephaloridine resulted in a fourfold
rise in infection rate.

Since cephaloridine is ineffective against

certain anaerobic bacteria, Polk inferred that anaerobic organisms
were not the prime source of infection.

It was suggested that only

the facultative component of such infections needs to be treated.
the other hand, Onderdonk et al. (1976) has suggested that
in an experimental mixed infection of

!·

fragilis and

necessary component for abscess formation.

!·

On

fragilis,

!· coli, was a

If this hypothesis is true,

treatment of !· fragilis alone would prevent abscesses from forming,
but would not prevent a potentially lethal peritonitis caused by facultative gram negative rods.
Treatment of

!· fragilis infections poses a very serious problem

because of the extreme resistance of this organism to many chemothera-
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peutic agents, including aminoglycosides (Finegold and Sutter, 1971),
&-lactam antibiotics and others (Kislak, 1972; Martinet al., 1972;
Zabransky et al., 1973).

Previously, tetracycline was the drug of

choice for anaerobic infections.
of

However, due to a rise in resistance

!· fragilis to this antibiotic (Nastro and Finegold, 1972) it is no

longer recommended.

Chloramphenicol is effective against B. fragilis,

but is reserved for seriously ill patients due to its association with
aplastic anemia (Finegold, 1975).

Clindamycin, the 7-chloro deriva-

tive of lincomycin, has been shown to be extremely effective against
B. fragilis (Haldane and van Rooyen, 1972).

However, because of its

association with pseudomembranous enterocolitis, now known to be
caused by a toxin produced by Clostridium difficile (George et al.,
1977), routine therapy with this antibiotic has often been avoided
(Cohen et al., 1973; Scott et al., 1973; Viteri et al., 1974).
Recently, good results have been obtained with carbenicillin against
anaerobic infections involving B. fragilis by in vitro testing
(Sutter and Finegold, 1975) and in vivo clinical studies (Meny et al.,
1975; Swenson and Lorber, 1976).

There have also been promising

results with metronidazole in the treatment of anaerobic infections
(Staneck and Washington, 1974; Whelan and Hale, 1973; Willis et al.,
1976; Tally et al., 1975), although this agent has not yet been
approved by the Federal Drug Administration for use in the United
States.
Another problem with the treatment of anaerobic infections concerns the ability of antibiotics to reach the extravascular site of
infection (Gerding et al., 1976).

A number of investigators (Alexander

F
15
et al., 1973; Tight et al., 1975; Gerding et al., 1976) have studied
penetration of antibiotics into subcutaneously or intraperitoneally
implanted capsules.

However, there has been great variability in

results due to bleeding, infection, differing routes of antibiotic
inoculation, and inconsistent degree of vascularity.
The most prevalent thought is that until a time when pathogenesis of these mixed infections is understood, therapy should be
directed against all significant components of the infection, including both aerobic and anaerobic bacteria (Finegold, 1977; Chow et al.,
1976; Thadepalli et al., 1973; Weinstein et al., 1974).

Chow and

Guze (1974) performed a prospective study in humans on the effectiveness of various antibiotic combinations for control of both aerobic
and anaerobic components, and indicated the need for both types of
antibiotics.

Other investigators (Bach et al., 1977; Griffith et al.,

1977) have also studied the effectiveness of various combinations of
antibiotic therapy in humans.
It is the purpose of this dissertation to critically investigate
the in vivo and in vitro interactions between B. fragilis and E. coli.
In order to approach this problem, the following studies will be
undertaken:

(1) An animal model of intra-abdominal abscess formation

will be developed in which the ability of

!· fragilis,

~·

coli, or the

combination of both organisms, to cause abscess infections in rats
will be studied; (2) The effect of type of bacteria, inoculum size
and suspending material on abscess formation will be studied; (3) The
nature of the interactions between
studied in vitro.

!· fragilis and !· coli will be

Finally, (4) factors produced by!· coli that
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stimulate the growth of B. fragilis will be partially characterized.

MATERIALS AND METHODS
I.

Isolation and maintenance of cultures.
Bacteroides fragilis subsp. fragilis (strain 8044) and Escheri-

chia coli (strain 8077) were used throughout this study.
organisms used were

!·

fragilis strains 2701, 8368, 7728, and 6880,

Klebsiella pneumoniae, Proteus vulgaris,
Staphylococcus aureus.

Other

Pseudomonas aeruginosa, and

All cultures were initially isolated from

clinical specimens by the clinical microbiology laboratories and kindly
provided by Dr. J. Vice, Foster G. McGaw Hospital.
The identity of all B. fragilis strains was confirmed using
techniques described by Holdeman and Moore (1972).

These included gas

chromatographic analysis and sugar fermentation testing.
prepared for gas chromatographic analysis as follows.
grown at 37°C for 48 h under anaerobic conditions
glucose medium (PYG, Difco Labs).

Samples were

Organisms were

in peptone yeast

Volatile acids were removed by

acidifying the culture and then extracting with ethyl ether (Mallincrodt, Inc.).

Non-volatile fatty acids were removed from the acidi-

fied culture by adding methanol and sulfuric acid, incubating at 55°C
for 30 min, and finally extracting with chloroform (Mallincrodt, Inc.).
Approximately 14

~1

of chloroform or ether was injected into a Beck-

man GC-5 gas chromatograph equipped with a hydrogen flame detector
and a Beckman recorder.

Chromosorb W 80-100 mesh in a 6' x 1/8 inch

stainless steel column was used with LAC-1-R-296 (diethylene glycol

+ adipate) as the partition liquid (Beckman Instruments, Inc.).
17
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gas \Liqu1a

ne~1um

~arooni~ ~orp.J

was usea as tne carrier, and a

combination of hydrogen and air (Liquid Carbonic Corp.) was used to
fuel the hydrogen flame detector.
Stock cultures of each strain were stored in 1.0 ml defibrinated
sheep blood (BBL) at -60°C (Model SZB-659, Revco Co.).

For routine

work, cultures were maintained at 37°C on blood agar (BBL) or enriched
media as described below.
II.

Media
A.

Liquid media.

these studies.

Several different complex media were used in

Enriched trypticase soy broth (enriched TSB) consisted

of trypticase soy broth (TSB, BBL), supplemented with 0.5% yeast
extract (BBL), 0.05% hemin (Eastman Organic Chemical Div., Eastman
Kodak Co.), and 0.0005% menadione (Sigma Chem. Co.), and was routinely
used for growth and maintenance of cultures.

It was also used for

studying oxygen and cold tolerance of anaerobic bacteria.

Bacto-pep-

tone (5%, Difco Labs), 5% tryptone peptone (Difco Labs), and 5% thiotone peptone (BBL) were tested for their ability to support growth of

!· fragilis alone,

~·

coli alone, or the combination of both.

On the

basis of these findings, Bacto-peptone was chosen for the study of
mixed culture interactions of

!· fragilis and

~·

coli.

A modification of the semi-synthetic medium of Roberts et al.
(1955) was also used to study mixed culture interactions.

The semi-

synthetic medium contained 1% Casamino acids (Difco Labs), 0.0026%
sodi~

sulfate, 0.3% potassium phosphate (monobasic), 0.3% sodium

chloride, and 0.0001% magnesium chloride.
autoclaving was 7.0.

The pH of this medium after

For certain experiments, Bacto-peptone or semi-
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synthetic medium was conditioned (spent) by aerobic growth of
for 24 h at 37°C.

~-

coli

The cultures were then centrifuged at low speed

(setting 6, International Clinical Centrifuge, International Equipment
Co.) to remove the bulk of bacteria and then filtered using a membrane
filter (0.45
B.

~m

pore size, Millipore Co.), for sterilization.

Solid media.

Enriched Trypticase soy agar (enriched TSA)

was prepared by the addition of 1.5% agar (Difco Labs) to enriched
TSB described above.

Blood agar (5% defibrinated sheep blood) was

obtained from BBL Laboratories.

To examine the survival of B. fragilis

at 4°C, Mueller-Hinton agar (BBL) and Schaedlers agar (BBL) supplemented with 0.05% hemin were used.

In some cases, when a minimal

medium for B. fragilis was required, TSA was used without supplementation.
C.

Selective media.

To selectively isolate !· fragilis from

E. coli in cultures containing both organisms, samples were plated on
enriched TSA containing kanamycin (Sigma Chem. Co.) or streptomycin
(Eli Lilly) to a final concentration of 100

~g/ml.

this concentration were found to inhibit growth of
allowing growth of!· fragilis.
mixed cultures containing

Aminoglycosides at
~-

coli, while

To selectively isolate!· coli from

!· fragilis, samples were plated on enriched

TSA and incubated aerobically.
D.

Vitamins, cofactors and supplements.

Bacto-peptone was

supplemented with various compounds, alone or in combination, and the
ability of !· fragilis to grow was then determined.
were:

Supplements added

0.05% hemin, 0.0005% menadione, vitamin B
(Sigma Chem. Co.),
12

ammonium sulfate, or a vitamin mixture (MEM-vitamin solution, lOOx,
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Lot Cl233C, Grand Island Biological Co.).

Several compounds were

tested to determine their effect on the survival of
4°C in enriched TSB.

!· fragilis at

For these experiments, various concentrations

of magnesium chloride, sucrose (Merck and Co., Inc.), calf serum
(Flow Labs, Inc.), or combinations of these materials were used.
Unless the source of chemicals was specifically mentioned, reagent
grade chemicals were used.
III.

Anaerobic system.
Routinely, cultures were placed in anaerobe jars using the BBL

Gas Pak system and incubated at 37°C.

In some experiments, individual

tubes or bottles were placed under anaerobic conditions by flushing
with 10%

co 2

and 90% N (anaerobe grade, Benster Specialty Gas Co.)
2

and tightly stoppered.
sample.

Each

bottle~

could then serve as an individual

Once the microenvironment of the bottle was disturbed by

sampling, it was discarded.
For experiments utilizing pus containing anaerobic bacteria,
samples were placed in a chamber maintained under reduced conditions
by flowing nitrogen gas (anaerobe grade, Benster Specialty Gas Co.).
IV.

Growth determinations.
A.

Turbidity.

Turbidity of cultures was measured in a Klett-

Summerson colorimeter using a red number Sq

filter.

curve of Klett units vs. viable cell number of
was prepared.

A standard

!· fragilis .or !· coli

Using this information, an inoculum of known concentra-

tion could then be prepared for in vivo or in vitro experiments.
B.

Viable counts.

Bacterial suspensions were appropriately
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diluted in enriched TSB or

steril~

distilled water and 0.1 ml was

spread with a sterile bent glass rod on the surface of the appropriate
agar medium.

Cultures containing
~·

mixed culture with
100 J..lg

kanamycin:~

!·

fragilis alone, or

!·

fragilis in

coli, were plated on enriched TSA containing

or streptomycin/ml, and incubated at 37°C for 24-48

h under anaerobic conditions.

Cultures containing

!·

coli were plated

in duplicate on enriched TSA and incubated at 37°C for 24 h under
aerobic conditions.

The number of colony forming units/ml of culture

were then determined.
V.

Susceptibility of B.
A.

Oxygen tolerance.

fra~ilis

to oxygen and low temperature.

To determine the ability of

!· fragilis to

survive exposure to atmospheric oxygen, approximately 100 cells were
plated on enriched TSA and exposed to atmospheric oxygen at room temperature.

After various time periods of oxygen exposure, plates were

incubated under anaerobic conditions at 37°C for 48 h and viable cell
counts determined.
B.

Cold tolerance.

For determination on solid media,

!· fragilis

was inoculated on enriched TSA plates to approximately 150 cells/
plate.

Sets of inoculated plates in separate jars were placed at a

specified temperature both under aerobic and anaerobic conditions.

The

anaerobic cultures were first incubated at 37°C for 1 h to obtain complete anaerobiosis.

At selected intervals, duplicate plates were

removed from each set and incubated at 37°C anaerobically to determine
the number of viable cells remaining.

To test the effect of chilling

on B. fragilis suspended in liquid media, 50 ml portions of enriched
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TSB were dispensed into 60 ml dropping bottles.

A sufficient number

of bottles were prepared so that each bottle would only be sampled
once before discarding.

Bottles were stored overnight in an incubator

at 37°C and then allowed to come to room temperature before use.
Bottles to be used for anaerobic cultures were preincubated overnight
at 37°C in a GasPak (BBL) anaerobe jar.

!·

with 0.5 ml of a diluted culture of
concentration of approximately 10
were immediately flushed with 10%

5

Each bottle was inoculated
fragilis to obtain a final

cells/ml.

co 2 +

The anaerobic cultures

90% N and tightly stoppered,
2

while the aerobic cultures were covered with sterile aluminum foil.
All bottles were then placed at the appropriate temperatures for
various lengths of time and viability counts determined.
The cold tolerance of microorganisms in pus collected from
experimentally produced abscesses was determined as follows:

Pus

was pooled from a number of abscesses and thoroughly mixed while kept
under anaerobic conditions.
containing 0.1 g of pus.

A series of tubes was prepared, each

Tubes were flushed with anaerobic gas and

then divided into three sets.

One set was placed at room temperature

and the second set at 4°C and the third set at l5°C.
sets of tubes were flushed with air.

Again, one set was placed at

room temperature and the others at 4°C and l5°C.
tightly sealed to avoid desiccation.

Another three

All tubes were

Duplicate sample tubes were

removed from each set at designated time periods and again weighed.
Five ml of saline (0.85% NaCl) were added to each tube, the tubes
mixed thoroughly, and viable counts were determined as a number of
organisms/g of pus.

p
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VI.

Int.eraction of B. fragilis and E. coli in vitro.
A.

Effect of E. coli growth on the growth of B. fragilis.

kinetics of growth of
first determined.
10

5

!·

The

fragilis and E. coli in a mixed culture were

!· coli and B. fragilis each at a concentration of

cells/ml were inoculated to enriched TSB.

At various times during

incubation, samples were removed, appropriately diluted in sterile
saline, and 0.1 ml was plated on solid media.

Number of E. coli was

determined by plating samples on enriched TSA and incubating aerobically.

The number of B. fragilis was determined by plating samples on

enriched TSA containing 100
ally.

~g

kanamycin/ml and incubated anaerobic-

Colony counts were performed 24 h .later after incubation at

To test the effect of the initial concentration of E. coli on
B. fragilis growth, the inoculum size of E. coli was varied from 101
cells/ml to 10

3

cells/ml.

Viable counts of each were determined at

designated intervals.
To determine the effect of selective inhibition of E. coli on

---

the growth of

!· fragilis in mixed culture, kanamycin was added to

the mixed cultures at designated time intervals.
added to a final concentration of 100

~g/ml.

Kanamycin was

Samples were taken at

designated times and viable counts were then determined as previously
described.
Since our preliminary experiments showed that growth of

!· fra-

gilis was enhanced when. it was incubated with E. coli, an experiment
was devised to determine if cell to cell contact was necessary for
this interaction.

B. fragilis and E. coli were physically separated

,
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by a dialysis membrane.

Dialysis tubing containing 50 ml of peptone

was placed into a flask containing 100 ml of the same medium.

Using

a bent glass tube, the medium inside of the dialysis tubing was inoculated with E. coli.
lated

with~·

fragilis.

Medium outside the dialysis tubing was inocuThe flask was then placed aerobically at

37°C and growth of B. fragilis observed after 24 h and 48 h.
B.

Effect of other organisms on B. fragilis growth.

was replaced by 10

5

cells/ml of Klebsiella

vulgaris in mixed culture growth.

E. coli

~neumoniae or Proteus

Ability to stimulate

~·

fragilis

growth was then determined at 24 h and 48 h as previously described.
C.
~bility

Effect of conditioned medium on growth of B. fragilis.

The

of E. coli conditioned peptone and semi-synthetic medium to

stimulate growth of

~·

fragilis was determined by two methods and

stimulatory factors then further characterized in conditioned semisynthetic medium.
1.

Test in liquid medium.

Various amounts of

!·

coli spent

medium, ranging from 0 to 50 ml, were added to 50 ml of stored medium.
The volume of medium in each tube was brought to 10 ml with sterile
saline.

All tubes were inoculated with 10

5

cells B. fragilis/ml, and

incubated anaerobically at 37°C·for 24 h.
2.

Test on solid medium.

The growth stimulatory activity

of spent media for B. fragilis was determined on solid media as
follows.
mately 10

The surface of TSA or enriched TSA was spread with approxi6

cells

of~·

fragilis.

Wells, 6.5 mm in diameter, were

cut with a metal ff5 cork borer and then filled with 0.25 ml of conditioned peptone or semi-synthetic media.

Plates were incubated at
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37°C under anaerobic conditions for

4~

h.

Stimulation was defined as

an enhanced growth around wells when compared to control wells containing saline or distilled water.
3.

Characterization of B. fragilis stimulatory factors

produced by E. coli.

The stability of the stimulatory factors under

various conditions was determined by treating separate samples of

!·

coli spent semi-synthetic medium in a variety of ways.

Spent

medium was placed in a boiling water bath for 30 min and then cooled
to room temperature.

Other samples were either (a) adjusted to pH

2.0 with HCl (Baker Chem. Co.), placed at room temperature for 1 h,
and then neutralized with NaOH, or (b) adjusted to pH 12.0 with NaOH,
placed at room temperature for 1 h, and then neutralized with HCl.
After determining stability of the stimulatory materials to
heat:,acid,and alkali, their physical and chemical properties were
further characterized.

Spent medium was dialyzed extensively against

distilled water to determine if the stimulatory materials were macromolecular, or relatively small molecules.
charged, Dowex 50 W, 100-200 mesh,

Cation exchange resin (Cl-

Sigma Chem. Co.), or anion ex-

change resin (ff+ charged, Dowex 1-XS, 100-200 mesh, Sigma Chern. Co.)
was used to remove negatively charged or positively charged materials
respectively.

Activated charcoal (Norit A, Baker Chern. Co.) was

used nonspecifically to remove certain substances.

To determine if

the stimulatory materials were lipid in composition, spent medium
was extracted with ether (Mallincrodt, Inc.).

All treated spent

media was then qualitatively assayed for stimulatory activity using
the solid medium assay

~s

described above.
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VII.

Antibiotic susceptibility.
~·

Susceptibility of

fragilis and

!· coli to cephalothin (Keflin,

Eli Lilly), cephalexin (Eli Lilly), cefazolin (Eli Lilly), cephaloridine (Eli Lilly), cefamandole (Eli Lilly), penicillin (Sigm Chem. Co.),
kanamycin (Sigma Chern. Co.), gentamicin (Schering), streptomycin (Eli
Lilly), and erythromycin (Sigma Chern. Co.) was determined and expressed as minimal inhibitory concentration (MIC).
Organisms grown anaerobically in enriched TSB for 24 h at 37°C
were diluted 1 to 100 into enriched TSB, and used as the inoculum.
This inoculum contained an average of 100 organisms/ml as determined
by viable cell counts.

The antibiotics were diluted in sterile dis-

tilled water and 0.5 ml of each antibiotic dilution plus 0.5 ml of
inoculum were added to 9.0 ml of enriched TSB to obtain final concentrations ranging from 0.39 to 1,000

~g

of antibiotic/ml.

were incubated at 37°C for 24 h in a GasPak system.

The tubes

The first tube

showing no turbidity was taken as the end point of the minimal
inhibitory concentration (MIC).
VIII.

Measurement of dissolved oxygen.
The dissolved oxygen level in broth media was measured using a

model 53 oxygen monitor equipped with a Clark oxygen electrode (Yellow
Springs Instrument Co.).

Measurements were obtained as percent of

total saturation of the medium with oxygen (saturation produced by
extensive vortexing).

In accord with the studies of Morris (1975),

the oxygen content of broth media for bacterial growth was accepted
as 250 pmoles oxygen/! at saturation.

Oxygen concentration of broth
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media in this study was
~moles

oxygen/! in
test medium

IX.

calculat~d

as follows:

= % saturation x 250

~moles/1

Preparation of superoxide dismutase (SOD) and its effect on

!· fragilis.
Superoxide dismutase was prepared from bovine blood (Lincoln
Slaughter House, Chicago, Ill.).

Red blood cells (RBC's) were

separated from 2 liters of citrated whole blood by centrifugation for
12 min at 4,000 g (Model B-20, International Equipment Co.) and
washed twice in saline.
The red
deionized water.

cells were lysed by diluting them 1:1 in distilled
Hemoglobin was then precipitated and the superoxide

dismutase was prepared by the procedure of McCord and Fridovich
(1969).
To determine superoxide dismutase activity, a nitro blue tetrazolium (NBT) assay was used (Beauchamp & Fridovich, 1971).

This

assay is based on the use of xanthine oxidase to catalyze the oxidation of xanthine, resulting in the generation of superoxide radicals.
NBT intercepts the radicals and becomes oxidized, resulting in an
increase in absorbance at 560 nm.

The reaction mixture consisted of

0.3 ml 2.2 x 10-8 N xanthine oxidase (Sigma), 1 x lo-3 N xanthine,
0.3 ml 2.5 x 10-4 N NBT (Sigma), 0.3 ml 1 x lo-3 N ethylenediamine
tetraacetic acid (EDTA), 0.3 ml 0.5 N sodium carbonate, 0.3 ml of
enzyme and 1.2 distilled water.

One unit of superoxide dismutase is

defined as the amount necessary to produce 50% inhibition of the rate
of reduction of NBT by xanthine oxidase.

The extracted SOD was found
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to have .an activity of 6.5 units/ml.

After determining the SOD acti-

vity, the crude extract was added in varying concentrations to Bactopeptone medium to test the effect of its presence on the growth of
B. fragilis.
X.

Experimental intra-abdominal abscess formation in rats.
A.

Animals.

Female white rats (outbred Sprague-Dawley albino,

Scientific Small Animal Laboratory and Farm, Inc., Arlington Heights,
Ill.) ranging from 250 to 300 g in weight were used in the present
investigation.

Animals were placed 5 per cage before and following

the surgical procedures and were maintained on Purina Rat Chow (Ralston Purina, St. Louis, Mo.) and water ad libidum.
B.

Preparation of implants.

introduce microorganisms into
their diffusion.

These were:

~he

Two types of implants were used to
abdominal cavity while minimizing

a) an artificial fecal material impreg-

nated with a bacterial inoculum, or b) a plasma or blood clot impregnated with a bacterial inoculum.

Artificial fecal material was pre-

pared by adding equal quantities of minced beef (80% lean hamburger,
Jewel Food Stores) to cellulose fiber (\fuatman filter paper, #1, W. &
R. Balston, Limited).

Filter paper had been broken into cellulose

fiber by mixing extensively in an Omni-Mixer (Sorvall, Inc.).

A small

piece (0.35-0.4 g wet weight) of autoclaved artificial fecal material
was placed inside a #0 gelatin capsule which was then inserted into a
#1 gelatin capsule.

Gelatin capsules (Eli Lilly & Co.) had been

sterilized by exposure to UV light (20 em from a Westinghouse Sterilamp 782L-20) for 48 h prior to use.

Cultures were grown for 18 to

..~.
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24 h in .enriched TSB and diluted to the desired concentration.
Immediately before implantation into animals, a predetermined number
of organisms was impregnated into the artificial fecal material.
Plasma or blood clots were prepared as follows:

male and

female rats (Locke-Erickson Co.), 400-500 gin weight, were bled by
cardiac puncture using 10 ml syringes that had been flushed with
heparin solution (Lipo-Hepin, 5000 units/ml, Upjohn Co.).

After

collection, the blood was placed into 0.7 ml red top Vacutainer
tubes containing Lipo-Hepin (Upjohn Co.).

The heparinized blood was

centrifuged to remove red blood cells, and the plasma then sterilized
by filtration through membrane filters (0,45
Corp.).

~m

pore size, Millipore

Immediately before surgery 1.0 ml of plasma was distributed

to each of the several tubes.

To prevent fibrinolysis 0.05 ml of

aminocaproic acid (Amicar, Lederle) was added to each tube.

The

plasma was inoculated with 0.1 ml of a bacterial suspension after
which 0.3 ml of thrombin (Parke-Davis, 5000 units/25 ml) was added
to initiate clot formation.

A firm clot formed within 30 seconds

that exhibited little, if any, fibrinolysis and clot retraction.

If

a blood clot was desired rather than a plasma clot, red cells were not
removed.
C.

Rat abdominal surgery.

Rats were anesthetized by intra-

muscular injection of 0.07 ml Innovar (fentanyl plus droperidol, Pitman-Moore, Inc.) •. The abdomen of each rat was then shaved and the
skin disinfected with 70% ethanol.

A 1.5-2.0 em incision was made on

the posterior midline through the abdominal wall and into the peritoneum so as to form an artificial capsule around the inoculum with

r-,/.

'
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,."'·

mesentery and intestine.

The peritoneum was closed with 4 or 5 con-

tinuous sutures of 3-0 monofilament (Ethilon, Ethicon Co.).
D.

Evaluation of abscess formation.

circumscribed collection of pus.
removed on day 42 and weighed.
microscopic examination.

An abscess was defined as a

Carefully isolated abscesses were
Smears of pus were prepared for light

Viable counts of B. fragilis and/or

!·

coli

from washings of the peritoneal cavity and of pus from the abscesses
were determined as previously described.
Animals that had been implanted with plasma clots or blood clots
were necropsied at 3 h, 6 h, 12 h, 24 h, 3 days, 7 days or 14 days.
Presence or absence of abscesses, as well as general appearance of the
animals, was noted.
E.

Histologic examination of intraperitoneal abscesses.

Animals

were necropsied at 1 day, 3 days, 7 days and 12 days after irnplantation of the artificial fecal material.

Histologic exaflination was

performed both on the abscesses and on tissues immediately surrounding the site of implantation.
Immediately after necropsy, tissues for histology were fixed in
buffered formalin (pH 7.2) for 48 h, embedded in paraffin, sectioned,
and stained with either hematoxylin-eosin (H and E) or phosphotungstic acid hematoxylin (PTAH).
XI.

Light microscopy and photomicrography.
All light microscopy was performed with a Nikon light microscope

fitted with both phase contrast and plain objectives.

Photomicro-

graphs were made on panchromatic film (Plus-X, Kodak) with a Nikon

31

camera equipped with an automatic exposure system attached to the
microscope.
XII.

Film was developed with Microdol developer (Kodak).

Analysis of data.
Determination of the statistical significance of differences

was made by using a Student's t test.
of

For comparing percent survival

!· fragilis and E. coli in pus after exposure to oxygen or low

temperature, and for analyzing differences in weight of intra-abdominal abscesses produced in rats, data were expressed as mean± standard
error of the designated number of values.
vival of

!·

For comparing percent sur-

fragilis and E. coli after in vitro exposure to oxygen or

low temperature, data was expressed as mean + standard deviation of
the designated number of values.

A difference was considered statis-

tically significant if the p value was less than 0.05.

RESULTS
I.

Characterization of B.

~ilis

used in this investigation.

Prior to actual experimentation with B. fragilis, its growth
characteristics, antibiotic sensitivity patterns, and susceptibility
/

to oxygen and low temperature were examined.

This was necessary

because the strain of ]!:> fra~ilis used (strain 8044) was a clinical
isolate which had not been previously characterized.
A.

Growth of B. fragilis in enriched TSB.

In order to stan-

dardize inoculum for in vitro and in vivo experiments, the time course
of growth of

~·

fragilis in enriched TSB and the relationship of cul-

ture turbidity to viable cell number were determined.
A typical growth curve

of~·

fragilis, obtained by the method

described in Materials and Methods, is shown in Fig. 1.
relationship

Since the

between Klett unit reading and viable cell number (24 h

cultures) held a linear correlation up to 10
units), an exact number

of~·

9

cells/ml (200 Klett

fragilis cells could be readily deter-

mined for inoculation purposes.
B. Antibiotic susceptibility of

~·

fragilis.

The susceptibility

of B. fragilis strain 8044 to various antibiotics is summarized in
Table 1.

This antibiogram was used for preparation of a medium that

would be selective for B. fragilis when mixed cultures of B. fragilis
and E. coli were studied.
Of all the cephalosporin derivatives tested,

~·

fragilis was most

susceptible to cephazolin, with a minimal inhibitory concentration
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Fig. 1.

Representative growth curve
37°C.

of~·

fragilis in enriched TSB at

Each point represents the mean viable count of duplicate

samples as described in Materials and Methods.
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TABLE 1.
MICa of various antibiotics for B. fragilis and E. coli

Antibiotic

MIC (JJg/ml) for
B. fragilis
subsp. fragilis

E. coli

Cephalothin

12.5

25

Cephalexin

12.5

25

Cefazolin

3.12

3.12

Cephaloridine

6.25

6.25

Cefamandole

6.25

Penicillin G

6.25

3.12

Kanamycin

> 1000

3.12

Gentamicin

> 1000

12.5;...25

Erythromycin

< 1.56

3.12

NDb

aMinimal inhibitory concentration (MIC) determined by
the broth dilution technique described in Materials
and Methods.
b

ND

= not

done.
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(MIC) of 3.12

~g/ml

(Table 1).

!· fragilis was also susceptible to

quite low levels of erythromycin with an MIC of

<

1.56

~g/ml.

B. fra-

gilis was not susceptible to any aminoglycoside tested, even at levels
of

>

1000

~g/ml,

confirming earlier reports (Finegold and Sutter,

1971; Martinet al., 1972).
C.

Survival of B. fragilis after storage in atmospheric

o~ygen.

During the collection, transportation, storage and handling of clinical
specimens containing anaerobic bacteria, some exposure to atmospheric
oxygen is unavoidable.

In order to determine whether !· fragilis

might be inactivated under our experimental conditions, sensitivity of
B. fragilis to atmospheric oxygen was determined.
During 24 h of oxygen exposure, essentially no
bility was lost (Fig. 2).
lost.

!· fragilis via-

Even after 72 h, only 2-3% viability was

This information indicates that handling and manipulation of

our B. fragilis strain can be undertaken on the bench under aerobic
conditions.
D.

Survival of B. fragilis after storage at low temperature.

In some cases during our investigation, mixed cultures containing
B. fragilis might be stored at low temperature to avoid the overgrowth
of coexistent facultative bacteria.

Finegold et al. (1974) recom-

mended that if specimens had to be stored for longer than 2 h, they
should be refrigerated to avoid this type of overgrowth.

However,

other investigators (Dowell and Hawkins, 1974; Finegold et al., 1974),
reported that low temperature was lethal for anaerobic bacteria and
that these organisms should not be stored in the cold.

To resolve

this controversy and to determine whether our experimental conditions

Fig. 2.

Survival

of~·

fragilis after exposure to atmospheric oxygen

and low temperature.

Predetermined numbers of 18 h old B.

fragilis cells were plated in duplicate on enriched TSA (o-o),
or suspended in enriched TSB

(~-~),

and then exposed to

chilling (4°C) for specified periods under aerobic conditions.
The number of surviving cells after exposure to 4°C was
determined as described in Materials and Methods.

Duplicate

sets of inoculated plates (enriched TSA) were left at 25°C
(•-•) under aerobic conditions.
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might cause a loss in viability of

!·

fragilis, sensitivity of

gilis to low temperature was determined.
can be seen in Fig. 2 and 3.

!·

fra-

Results of this experiment

!· fragilis was killed rapidly at 4°C,

but there was essentially no loss of viability at 25°C.

A similar

loss in viability at 4°C was observed when!· fragilis was plated on
enriched Mueller-Hinton Agar, enriched Schaedler's agar, or blood
agar (Fig. 3).

Although data are not shown here, other strains (8268,

7728, 6880 and 2701) of B. fragilis exhibited a similar sensitivity to
low temperature.
The effect of chilling on!· fragilis in liquid medium was also
tested.

Over 50% viability was lost within the first 12 h after which

the rate of loss slowed until a loss of 80% viability was demonstrated
at 72 h (Fig. 2).
In order to clarify whether this inactivation of B. fragilis at
4°C was due to the lethal effect of a higher oxygen concentration
dissolved in the cold media, or due to injuries induced by cold, we
determined the loss of viability of B. fragilis exposed to low temperature (4°C) under both aerobic and anaerobic conditions.

It appears

.

that the inactivation of !· fragilis was a result of cold injury since
loss of viability occurred at 4°C either in the presence or absence of
oxygen (Fig. 4).

Under aerobic conditions, cells suspended in liquid

media (Fig. 4B) appeared to be more susceptible (p
than those plated on solid media (Fig. 4A).

<

0.005) to cold

However, under anaerobic

conditions there seemed to be no significant difference in the extent
of killing of B. fragilis between solid and liquid media.
To determine if the ability to survive prolonged exposure to low

•
Fig. 3.

Survival of B. fragilis after exposure to low temperature.

Pre-

determined numbers of 18 h old cells were plated in duplicate on
various solid media. and exposed to 4°C and 25°C for a specified
time under aerobic conditions, and the numbers of surviving
cells were determined as described in Materials and Methods.
Symbols:

,-,, enriched Mueller-Hinton Agar; x-x, enriched

Schaedler's Agar; o-o, enriched TSA; 6-6, commercial blood agar.
Solid lines represent the exposure at 4°C and the dotted line
represents the exposure at 25°C.
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~ Aerobic condition

Survival of~· fragilis after storage of fresh isolates at low
temperature.

~ Anaerobic condition

Predetermined numbers of cells were either sus100

pended in enriched TSA (A), or plated on enriched TSB (B) and
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A

exposed to 4°C both under aerobic and anaerobic conditions for
12 h and the numbers of surviving cells were determined as
described in Materials and Methods.

The controls refer to

the number of ~· fragilis cells inoculated at time 0.
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temperature differed between cells in exponential phase (6 h) and
stationary phase (18 h), cultures of both ages were exposed to low
temperature (Fig. 5).

Under all conditions tested, older cultures

(18 h) were more susceptible to chilling than younger cultures (6 h).
Tally et al. (1975) noted that repeated subculturing of !· fragilis
might reduce its susceptibility to oxygen.

To examine this possibil-

ity, the decrease in susceptibility of !· fragilis (18 h culture) to
chilling after repeated transfers on blood agar medium was determined
(Fig. 6).

!· fragilis cells transferred on blood agar more than 15

times became significantly (p < 0.05) more tolerant to cold than the
fresh isolate.
In attempting to minimize the lethal effect of low temperature
on B. fragilis, various materials were added to enriched TSB before
storage
on~-

of~-

fragilis (Table 2).

The detrimental effect of chilling

fragilis was minimized when 5 mM magnesium chloride and 1.0 M

sucrose were added.

Calf serum or divalent cations alone added to the

enriched TSB did not protect

~-

fragilis from the lethal effect of low

temperature.
From the above data, it is obvious that long periods of exposure
to low temperature are lethal to !· fragilis under most conditions
tested, and that storage of this organism at low temperature should be
avoided.
E.

Survival. of B. fragilis in experimentally produced pus.

To

determine whether B. fragilis cells in pus were similarly affected by
low temperature, pus containing!· fragilis, !·coli, or mixed cultures
of both organisms, was collected from experimental animals and tested.
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Fig. 5.

Survival of exponentially growing and stationary phase~· fragilis.
after storage at low temperature.

Predetermined numbers of 6 h

and 18 h and old ~· fragilis (freshly isolated) were either
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on enriched TSA (A and B) or suspended in enriched TSB (C and D)

A

and exposed at 4°C for 12 h, either under aerobic conditions (A
and C), or anaerobic conditions (Band D).

The numbers of sur100

viving cells were determined as described in Materials and Methods
The controls represent the number of ~· fragilis cells inoculated
at time 0.

Mean and standard deviation of at least 3 values are

indicated on each bar.

..J

~
·>
a::

80

:::>

en
.__

z
~
a::
w

a.

20

6h

D

Control

£:§3 6h old cells

m5J ISh

ISh

old cells

42

.....

.

#,

100

Fig. 6.

A

8

c

D

Survival of subcultured ~· fragilis after storage at low
temperature.

Predetermined numbers of either freshly isolated

or repeatedly subcultured

1!·

fragilis (both •.rere 18 h cultures)

were plated on enriched TSA (A and B), or inoculated in en-
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riched TSB (C and D), and exposed at 4°C both under aerobic
(A and C) and anaerobic (B and D) conditions.

The number of

surviving cells after 12 h of exposure was determined as
described in Materials and Methods.

The controls represent

the number of cells inoculated at time 0 (approximately 1 x 105
cell/ml final concentration).

Mean and standard deviation of at

least 3 values are shown on each bar.
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TABLE 2.
Effect of selected compounds on the survival of

B. fragilis at 4°C in enriched TSBa
Stored in
enriched TSB
plus:
None
1 mM MgC1
5 mM MgC1

10

5 mM MgC1

5 mM MgC1
5 mM CaC1
5 mM Cac1

4

2

13

2

10 mM MgC1
5 mM CaC1

% Survival
after 12 h

2

9

2
2
2
2
2

6

+ 0.1 M Sucrose

11

+ 0.5 M Sucrose

48

+ 1.0 M Sucrose

97

+ 0.5 M Sucrose

30

10% Calf serum

8

20% Calf serum

9

50% Calf serum

11

aTrypticase soy broth containing yeast
extract (0.5%), hemin (0.05%), and
menadione (0.0005%).
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Percent of survival of B. fragilis in pus, in which
only infectious agent, is shown in Fig. 7A and B.

!·
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fragilis was the

B. fragilis in the

pus lost viability slowly but progressively at 4°C whether it was
stored under aerobic or anaerobic conditions.

However, when it was

stored at 25°C, no significant loss of viability occurred within 24 h
under both aerobic and anaerobic conditions.

Since most anaerobic

infections are mixed infections containing both strict and facultative
anaerobes, we investigated the survival of
pus in which both microorganisms coexisted.
experiments are summarized in Fig. 8.

!· fragilis and !· coli in
The results of these

While the survival pattern of

!· fragilis in such pus (Fig. SA and 8C) was similar to that seen
above (Fig. 7A and 7B), there was a significant increase in number of

!·

coli when pus was stored at 35°C (Fig. 8B and 8D).

Apparently,

chilling was also detrimental to E. coli whether pus was stored under
aerobic or anaerobic conditions.

In an effort to find an alternative

condition for storage of pus that allows the maximum number of B.
fragilis to survive while suppressing the overgrowth of coexistent
E. coli, we tested the survival of both organisms in pus stored at l5°C.
The results of such an experiment are summarized in Table 3.
apparent that, at this temperature, most

It is

!· fragilis remained viable

for at least 24 h while the overgrowth of coexistent E. coli was
minimized.
F.

Preliminary animal experiments.

In an attempt to establish

an intra-abdominal abscess model suitable for studying the interaction
between B. fragilis and!· coli in vivo, several preliminary experiments were performed.
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Fig. 7.

Survival of!· fragilis in pus after storage at 25°C or 4°C.
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termined as described in Materials and Methods.
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TABLE 3.
Change in viable cell number of !·

fra~ilis
..

,

,;

and

!•

coli in pus at 15°C,

.~

%of original inoculum+ S.E.a
Time (h) of
storage

_!!. fragilis
(monoinfection)

_!!. fragilis
(mixed infection)

c

E. coli
(mixed infection)

aerobicb

anaerobicc

aerobicb

anaerobicc

100 + 3

100 + 2

100 + 2

100 + 10

100 + 10

84 + 6

116 + 8

86 + 6

66 + 9

106 + 6

86 + 9

76 + 13

87 + 5

94 + 11

73 + 3

129 + 30

130 + 7

aerobicb

anaerobic

0

100 + 3d

2
24

aStandard error
bstored aerobically
cStored anaerobically
d

Each figure represents the mean of at least three samples
~
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1.

I~.1oculation

of bacterial suspensions.

Rats (5 per group)

were implanted with gelatin capsules containing a suspension of 10

cells~- fragilis or 10 8 cells ~· fragilis plus 108 cells

8

E. coli.

By

24 h, a lethal peritonitis had resulted in 100% mortality of animals

implanted

with~·

fragilis and!· coli.

On necropsy, intraperitoneal

abscesses could not be detected (Fig. 9C).
by 15 din animals implanted

with~·

No mortality was observed

fragilis alone (Fig. 9A).

Repre-

sentative animals from this group were necropsied at 4 d, 8 d, or 15
d.

Peritonitis could not be detected at any time, and intraperitoneal

abscesses did not form.
This model is not suitable for our studies because of the lack
of formation of intraperitoneal abscesses.

Abscesses probably did not

form because of the rapid diffusion of microorganisms from the area of
implantation.

2.

Implantation of rat fecal material.

Intraperitoneal

abscesses often result from some type of trauma or surgery that causes
spillage of colonic contents.

Rats (5 animals) were implanted with

gelatin capsules containing rat fecal material as described previously
by Deysine et al. (1967).

As seen with the previous model, allanimals

formed well defined abscesses (Fig. 9B), and lived until necropsy at
15 d.
Although this model is effective in causing anaerobic intraabdominal abscesses, several problems make it unsuitable for a critical study of such infections.

These include the undefined nature of

feces, the multiplicity of bacterial species, and also the bacterial
end products that lend to the complexity of this system.

...

;

.·

Fig. 9.

Rats infected
with~·

with~·

fragilis,

~·

fragilis in combination

coli, or with rat fecal material.

Animals (5 rats

per group) were implanted with a single gelatin capsule
containing (A) 108 cells of ~· fragilis, (B) fresh rat fecal
material, or (C) 10
~-

co1i .

8

A11 a nim a 1 s

1n f ected w1th

~·

cells of

~·

fragilis and 108 cells of

in gro up C were dead

by

24 h.

Anim a 1 s

frag111s a1one or rat feca1 mater1a1 were

necropsied on day 15.

As designated by the arrow in B,

abscesses were reproducibly formed in animals infected with
the fecal material.

.p..
1.0

50

3.

Implantation of bacteria impregnated in "artificial feces."

To avoid the problems of using actual fecal material to cause
abscesses, an artificial feces was developed.

This was defined as a

mixture of sterile ground meat and cellulose fiber, into which a known

-

bacterial inoculum had been impregnated.

The artificial feces was

then placed into a gelatin capsule and implanted in the peritoneal
cavities of rats.
I

Intra-abdominal abscesses were formed when the artificial fecal
material contained certain bacteria or bacterial mixtures.

The ulti-

mate size ~f these abscesses depended on the types of bacteria which
had been impregnated into the sterile meat and cellulose.
It is obvious from these results that it is possible to utilize
the basic model of Deysine et al. (196 7) to cause intraperitoneal
abscesses

while retaining the ability to carefully define the inocu-

lum size and composition implanted into rats.

For this reason, the

artificial feces model of intra-abdominal abscess formation was adopted for our studies.
II.

Interaction between B. fragilis and E. coli
A.

in vivo.

Enhancement of B. fragilis pathogenicity by E. coli.

The rat

intra-abdominal abscess model developed by Deysine et a1. (1967) and
used by Weinstein et a!. (1974) was modified (see Materials and Methods)
to determine whether the pathogenicity of
by!· coli.

!· fragilis could be enhanced

The results of the experiments using the modified animal

model are summarized in Table 4.
When gelatin capsules, containing artificial fecal material
impregnated with B. fragilis alone, !· coli alone, or the combination

-w~

:~

TABLE 4.
Average weight and bacteriological data
of abscesses experimentally produced in rats
Organisms impregnated
in artificial fecal
a
Group
material

(g)

1

No bacteria

0.69 + 0.22

2

!· !§agilisd
(10 cells)
e
!· Egli
(10 cells)

0.73 + 0.40

B. fragilis
- (108 cells)
and
E. coli
-(100Cells)

3
4

a

Weight of encapsulated material
b

Frequency of
abscess
formation (%)
oc

Organisms recovered from
peritoneal cavity

pus (cells/g)

Sterile

Sterile

100

Sterile

B. fragilis
-3.2 X 109

2.80 + 1. 22

100

Sterile

!· coli
8
3.85 X 10

4.04 + 1.69

100

Sterile

B. fragilis
-6.5 X 109
and
!· coli 9
1. 7 X 10

/

10 animals were used for each group.

b Mean + standard deviation.
c Since only sterile artificial fecal material was found within the encapsulation, we did not consider these as abscesses.
10
d The Ln
of!· fragilis for rats could not be determined with an inoculum of as high as 10
cells.
50
None of the animals had died at 42 days and abscesses were minute in size with all doses of !· fragilis used.
5
e
8
ThP. LD
of!· coli for rats was 1.15 x 10 cells. All surviving animals from groups given 10 to
50
9
10 !· coli exhibited large intraperitoneal abscesses at 42 days. None of the animals given 106
E. coli died within the 42 days of observation.
IJ1
1-'
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of both organisms, were implanted into the peritoneal cavities, various
sizes of abscesses were formed intra-abdominally in 42 days (Table 4).
Implantation of capsules containing artificial feces alone resulted in
encapsulation of the inoculum without the marked accumulation of pus.
Representative photographs of rats from each experimental group are
shown in Fig. 10.

When 10

8

cells of B. fragilis were added to the

artificial fecal base and implanted into the peritoneal cavity, only
small intra-abdominal abscesses were formed (Fig. lOB).

r

,
~··
'

weight

fragilis induced abscesses was 0.73 g

of~·

The average

± 0.40,

not signi-

ficantly larger than the encapsulated granule produced by the sterile
artificial fecal inoculum (0.69 g + 0.22).
pure culture was isolated at 3.2 x 10
10

6

cells of

~.

9

However, ~· fragilis in

cells per gram of pus.

When

coli were added to the artificial fecal base and

implanted into animals, large abscesses (2.80 g

± 1.22)

were formed

(Fig. lOC) which were significantly larger than the control group
(p < 0.001).

The abscesses produced by E. coli contained larger

quantities of pus than abscesses caused by
to contain 3.85 x 10
4).

When 10

8

8

cells of viable

!·

cells of!· fragilis and 10

~·

fragilis and were shown

coli per gram of pus (Table
6

cells of E. coli were com-

bined and implanted into animals (Fig. lOD), the resultant abscesses
(4.04 g

± 1.69)

were significantly larger than the control (p < 0.001)

or those formed by!· fragilis alone (p < 0.001), although they were
not significantly different from those produced by
0.10).

!· coli alone (p

Abscesses produced by the combination of both organisms were

filled with pus that contained both viable E. coli and !· fragilis
(1.7 x 10

9

and 6.5 x 10

9

cells/g pus, respectively).

In all cases,

<
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·
.

~

·.

Fig. 10 .

Intr a - abdom~nal
~·

abscess formed in rats by!· coli or

fragili s or by the combination of both organisms.

Animals (10 rats per group) were implanted with a
double gelatin capsule containing artificial feces
impregnated with (A) no bacteria (control), (B) 10 8
B. fragilis cells, (C) 10 6 !· coli cells , or (D) 10 8
B. fragilis cells combined

.

w~th

10

6

E. coli cells .

Arrows indicate the encapsulated sterile feces in
Fig. lA, and the abscesses (Fig. lB to lD) formed in
rats as specified above.

r
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the periconeal cavity of the rats was sterile at the time of necropsy.
Both

~.

fragilis and

~·

peritoneal abscesses in rats.

coli alone caused the formation of intraThe combination of these organisms

caused abscesses that appeared larger than those caused by either
alone, although they were not statistically different in weight from

C'

those induced by E. coli.

These results are significantly different

:~:

from those reported by Onderdonk et al. (1976) in that!· fragilis and

!· coli could independently cause intraperitoneal abscesses to form.
To our knowledge, this is the first demonstration of intraperitoneal
abscesses caused by a facultative anaerobe alone.

Onderdonk et al.

(1976)-reported that neither organism could cause abscesses unless the
other was present.
B.

Lethality of B. fragilis and E. coli for the rat.

In order

to determine the maximum number of E. coli or B. fragilis that could
be implanted in the rat to cause abscess formation without causing
lethality, the tn

50

of each organism was determined.

!· fragilis in concentrations ranging from 10

5

to 10

10

cells/ml

was impregnated in artificial fecal material and implanted into the
peritoneal cavity of rats.

The tn

50

of !· fragilis in this model

system could not be determined with an inoculum as high as 10

10

cells.

None of the animals had died by 42 days postoperatively.
E. coli in concentrations ranging from 10

5

to 10

10

cells/ml was

also impregnated into artificial fecal material and implanted in rats.
The LD
x 10

8

50

of

!·

coli for rats in this model system was found to be 1.15

cells.
On the basis of these findings, an inoculum of 10

8

cells B. fra-

r'
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gilis, 10

6

cells~·

coli, or the combination of both organisms was

used in our animal model of anaerobic infection.
C.

Histology of experimentally produced abscess.

logic examination of abscesses caused by
combination of both, was performed.

The histo-

!· fragilis, !· coli or the

A typical cross section through

an abscess formed by implantation of gelatin capsules containing
artificial fecal material impregnated by

!·

fragilis and E. coli is

shown in Fig. 11.
The outside of the abscess is seen to the right of the micrograph.

In the older, outermost area of the abscess wall, granulation

tissue (GT) and proliferation were evident with fibrosis extending to
the surrounding adipose tissue (A).

Closer to the lumen of the

abscess, (L) there were increasing numbers of phagocytic cells (P).
Plasma cells and macrophages were more prominent in this area.

In

the lumen of the abscess was a large amount of exudate, primarily
debris, bacteria and polymorphonuclear leukocytes.

This histopatho-

logic description is also typical for abscesses sectioned from human
tissues.

There was no difference in histologic appearance of this

abscess and those caused by

!· fragilis alone or E. coli alone when

animals were necropsied at 42 d.
Since differences in response to these organisms might be more
visible at an earlier time after implantation, tissue surrounding the
gelatin capsule and artificial fecal material was observed histologically at 1 d, 3 d, and 7 d postoperatively.

At 24 h after implanta-

tion, tissue surrounding the abscess caused by

!· fragilis or the

combination of B. fragilis and E. coli was found to have microthrombi

.·.

.;

~

Fig. 11.

Cross section of an intra peritoneal abscess formed in rats by
implantation of 10 8 cell s
E. coli.

~· fragilis cell s and 106 cells of

Animals were i mplanted with a dou ble gelatin cap-

sule containing artificia l fecal material a s described in
Materials and Methods and were necropsied a t 42 days.

Abscess

tissue was fixed in buffe red formalin, embed ded in paraffin,
sectioned, and stained wi th Hand E.

Lette r s:

(L) lumen,

(P) phagocytic cells, (GT) granulation tis sue, (A) adipose
tissue.

'I
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present.

However, microthrombi seen at this time could be

~xplained

by the severe vasculitis observed and not necessarily to any specific
response of

!·

infected with

fragilis.

!·

It is interesting that at 7 d, tissues

fragilis appeared to have an arterialization of the

capillaries in the granulation tissue.

However, the meaning of this

finding is, as yet, obscure.
It is clear from this brief examination of tissues that the
response seen in animals infected with B. fragilis (or combinations
with

!·

,coli) is different from that seen in animals infected with

E. coli alone.

Extensive studies need to be performed to determine

what is causing these pathogenic effects and to study them more
critically in vitro.
D.

Factors affecting intraperitoneal abscess formation caused

by B. fragilis.

To study the actual role of each bacterial component

pathogenesis, the effect of inoculum size of B. fragilis and/or E.
coli, on abscess formation were determined.
1.

Effect of inoculum size on abscess formation.

size of B. fragilis inoculum was varied from 10

7

to 10

10

When the

cells,all

abscesses formed were small and not significantly different in weight
from the encapsulated mass seen in the control animals (Table 5).
Variation in the inoculum size of E. coli from 10

6

cells to 10

did not result in any difference in abscess size (Table 6).
abscesses caused by an inoculum of 10

7

or 10

slightly smaller than those caused by 10
lum of higher than 10

8

6

8

cells of

!·

8

cells

In fact,

coli were

cells of E. coli.

An inocu-

cells resulted in lethal peritonitis.

When animals were implanted with both B. fragilis and E. coli

,~,

TABLE 5.

Average weight of abscesses experimentally
produced in rats by ~· fragilis

Number of !· fragilis impregnated in artificial fecal material

Group

Number of
animals

1

10

None

0.69 + 0.09 b

2

4

1010 cells

0.85 + 0.26

3

4

109 cells

0.73 + 0.03

4

10

108 cells

0.73 + 0.13

5

4

a

10

7

cells

Weight of encapsulated materiala

0.67 + 0.33

Mean + standard error

b When no bacteria were impregnated, only sterile artificial fecal material
was found within the encapsulation and no pus was formed.

VI
00

,
TABLE 6.
Average weight of abscesses experimentally
produced in rats by E. coli
Group

Number of
animals

Number of E. coli impregnated
in artificial fecal material

1

10

None

0.60 + 0.09

2

10

10

cells

2.18 + 0.41

3

8

10

cells

2~94

4

8

10

cells

4.04 + 0.56

a

8

7
6

Weight of encapsulated materiala
b

+ 0.31

Mean + standard error.

b When no bacteria wer.e impregnated, only sterile artificial fecal material was
found within the encapsulation and no pus was formed.

Vl
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r
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(Table 7) even small numbers of bacteria were sufficient to cause the
formation of large abscesses.

B. fragilis, _§. coli or both in combination are seen in Fig. 10.
2.

t;
~

Representative abscesses caused by

Effect of suspending material on abscess formation.

Intraperitoneal abscesses are most often associated with trauma or
spillage of intestinal contents into the abdomen.

As shown above, an

artificial fecal material in conjunction with bacteria was necessary
to cause infection.

This closely mimics colonic spillage without

introducing the complexities of actual fecal material.
Another factor associated with ability of these organisms to
initiate infection might be the presence of clots formed during trauma
f\ .

or abdominal surgery.

Although the clots resorb internally after a

short time interval, they might still serve as an initial focus of
infection.
Animals implanted with plasma clots that had been impregnated
with bacteria did not cause the formation of intraperitoneal abscesses
by day 7.

Clots began to dissolve immediately on implantation and had

disappeared by day 7.

In contrast to this when blood clots were im-

pregnated with bacteria, small well defined abscesses formed and persisted to necropsy on day 14 (Fig. 12).
of bacteria was necessary initially.

It appears that localization

However, if blood is present and

a focus of infection forms, suspending material might not be necessary,
and pathogenicity 9f the organisms could be determined without the
further complication of a prolonged foreign body response.
It appears that for intra-abdominal abscesses to form, localization of bacteria was initially necessary.

However, after initiation

.·

. .,.,

>·-··~

·~..----

..,

.........

TABLE 7.
Average weight of abscesses caused by
low numbers of B. fragilis and E. coli

Group

Number of
animals

1

10

No bacteria

0.69 + 0.09

2

5

~· fragilis 4 (10 4 cells)
E. coli (10 cells)

3.26 + 0.41

3

4

4

5

5

4

•

a

Organisms impregnated in
artificial fecal material

~

.

B. fragil~(lo- cells)
E. coli (10 cells)
2
!!_. fragilis (10 cells)
E. coli
.,... - -

~· fragilis 1 (10 1 cells)
_§,. coli .ClO cells)

Weight of encapsulated material a
b

3.28 + 0.49
3.20 + 0.21
2.48 + 0.49

Mean + standard error.

b When no bacteria were impregnated, only sterile artificial fecal material
was found within the encapsulation and no pus was formed.

"'
1-'
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Fig. 12.

Intra-abdominal abscess in rats caused by implantation of blood clots impregna ted with 108 cells of
~·

fragilis .

The arrow indicates a representative

abscess formed in rats as specified above.

63
of the infection, solid material was no longer necessary.

It should

also be noted that the presence of blood was necessary, possibly due
to its content of nutrients, vitamins, and/or ·iron.
III.

Effect of E. coli on the growth of B. fragilis in vitro.
Although data from other investigators (Onderdonk et al., 1976)

suggest that a synergistic interaction between aerobic and facultative
organisms is involved in abscess formation, it is still not clear from
our data (Table 4, Fig. 10) whether B. fragilis and E. coli actually
interact to enhance the formation of intra-abdominal abscesses in rats.
In order to investigate the nature of interactions between these two
organisms more critically, their growth in_a mixed culture was examined in vitro.
A.

Growth of B. fragilis and E. coli in peptone media.
1.

E. coli.

==

Enhancement of
.,

!· fragilis growth in the presence of

B. fragilis rapidly lost viability when incubated alone in

stored Bacto-peptone broth (lot #540620) at 37°C.
however,

In the same medium,

!· coli grew optimally with a short lag period and a doubling

time of approximately 20 min (Fig. 13).
ed in the same medium together with

When B. fragilis was inoculat-

!· coli, the B. fragilis showed an

initial
decline in viability as it did in pure culture.
4

However, after

9 h to 12 h of incubation, growth of B. fragilis was initiated and
eventually reached near maximal levels of growth in 24 h.

This pheno-

menon was repeatedly observed whether the mixed cultures were incubated under aerobic or anaerobic conditions.

In one particular lot of

Bacto-peptone broth (Difco, peptone, lot #630023) the viability of

.·~ ;

"
Fig. 13.

Enhancement of B. fragilis growth by!· coli and change
in dissolved oxygen level during incubation.

"'

Cells were

grown in Bacto-peptone (lot #540620) under aerobic conditions at 37°C for 24 h.

Dissolved oxygen ( o-o) was

measured using an oxygen monitor equipped with a Clark
oxygen electrode.

Each point represents the mean of at

least two samples.

Symbols:

•-•, viable!· coli when

grown alone or in combination with B. fragilis; IJ.-IJ.

-

'

e-e, viable !· fragilis when grown

viable _!!. fragilis alone;

with E. coli in a mixed culture.
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~·

fragilis in a mixed culture dropped so rapidly that essentially no

viable

~·

fragilis cells could be recovered from the culture by 3 h
However,~·

(Fig. 14).

fragilis growth initiated at 12 hand progress-

ed normally, reaching the maximal level by 24 h.

These observations

clearly indicate that under this condition, the initial growth of E.
coli is required for the subsequent growth of
2.

~·

fragilis.

Suitability of various peptone media for studying the

in vitro interaction between B. fragilis and E.

~·

Because it was

experienced in the early phase of this in vitro study that reproducible results could be obtained only when the same batch of peptone was
used, various peptone media were examined to see whether only certain
types of peptone were suitable for the present study.
Various lots of Bacto-peptone and other commercially available
peptone media were tested under the same experimental conditions as
employed for testing the lot /1540620.
summarized in Tables 8 and 9.
growth of

The results of the test are

As evident in the tables, good to fair

!· fragilis occurred in the absence of E. coli in most of the

peptone media tested.

Although data are not shown, all peptone media

supported good growth of

!·

coli.

Since it was desirable for our pur-

pose to use a medium in which B. fragilis could grow only in the presence of E. coli, it was decided to use Bacto-peptone lot #540620
throughout the subsequent study.
3.

Enhancement of B. fragilis growth by E. coli while

separated by a dialysis membrane.

To determine if physical contact

between the two organisms is necessary for

!·

fragilis growth to occur,

the organisms suspended in peptone broth were separated by a dialysis

.:A;

.,
Fig. 14.

Enhancement of B. fragilis growth by
peptone (lot #630023).

!·

~

,.

in Bacto-

Cultures were grown under aerobic

conditions at 37°C for 24 h.

Each point represents the

mean of at least two samples.

Viable cell numbers of less

than 10 cells/ml could not be detected.

In some cases,

cell number dropped below this limit and were again countable at a later time.

Symbols:

•-•,

!

coli alone or in

combination with!· fragilis; j-£, !· fragilis alone;

e-e,

·d
E

!· fragilis growing with

•

~

• --::11

!·

coli.
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TABLE 8.
Growth of B. fragilis and oxygen levelsa in
various peptone media (5%)
b

Medium

Time
storedc (h)

Growthd
(Klett units at 540)
24 h
48 h

Dissolved
e
oxygen
(Jlmo1es/1)

Bacto-peptone

0
24
48

48
0
0

60
0
0

30
67.5
192.5

Tryptone

0
24
48

46
32

45
100

15

97
96
90

0
24
48

75
75
21

109
110
105

40
120

Thiotone

a

b

ND

ND

Growth and oxygen levels are representative of at least 2
determinations.
Supplemented with 0.05% hemin.

c Stored at room temperature for 24 h under aerobic conditions.
d

e

The medium was inoculated with 2.5 x 10 5 B. fragilis cell/ml,
and incubated under anaerobic conditions at 37°C.
Measured by a Clark type electrode immediately before inoculation.
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TABLE 9.
Growth of B. frasilis in various
lots of Bacto-peptone mediuma (5%)

Lot number

Growth5
(viable cells/ml)

540620

10
104

561172

7,8

564852

1.7x 10 2

604607

1.19

X

10 9

630023

1.41

X

109

X

a Stored at room temperature for 24 h
under aerobic conditions and supplemented with 0.05% hemin.
b The media was inoculated with 2.5 x
10 5 !· fragilis cells/ml and incubated
under anaerobic conditions at 37°C
for 48 h. Growth is representative of
at least 2 determinations.
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membrane and then incubated aerobically at 37°C (data not shown).
After 24 h of incubation,
approximately 10

5

~·

coli grew from an original inoculum of

cells/ml to an optimal level of 10

whereas no growth of

~·

fragilis occurred.

9

cells/ml,

In fact, viable number of

~· fragilis dropped from 105 to 103 cells/ml within that period.
However, by 48 h, ~· fragilis grew to a level of 2 x 10

7

cells/ml.

A similar result was obtained when the same culture system was incubated anaerobically.

These results indicate that direct cell to cell

contact is not necessary for enhancement of B. fragilis growth by
E. coli and that a possible factor(s) involved is dialyzable.
4.

Effect of selective inhibition of E. coli growth on the

survival and growth of B. fragilis in mixed culture.
inhibitory to the growth of
~·

the extent of

~·

Kanamycin is

coli but not B. fragilis.

To determine

coli growth necessary for survival and subsequent

growth of coexistent!· fragilis, kanamycin (100

~g/ml,

final concen-

tration) was added to separate sets of mixed cultures at various times
of incubation.

The results of these experiments are illustrated in

Fig. 15.
When kanamycin was added to the mixed culture at 0 time,

~·

coli

rapidly lost viability and dropped to a level of 20 cells/ml at 4 h
and no growth of B. fragilis was observed (Fig. 15A).

When the anti-

biotic was added at 2 h to the mixed culture in which E. coli had
grown from 10

5

rapidly killed.
2 x 10

6

cells/ml to 2 x 10

6

cells/ml, most of the E. coli were

However, B. fragi1is began growing at 10 h, reaching

cel1s/ml at 24 h.

In case kanamycin was added at 4 h (Fig.

15C), when E. coli had grown to 10

8

cells/ml, initiation of!· fragilis

.~~

;

"'

•·

"
Fig. 15.

Effect of!· coli on the growth of!· fragilis in
Bacto-peptone medium.

Cultures were grown under aerobic

conditions at 37°C for 24 h.

Kanamycin (100

~g/ml)

was

added at 0 time (A), 2 h (B) or 4 h (C) to selectively
inhibit !· coli growth.

Viable counts were determined

as described in Materials and Methods.

Each point re-

presents the mean of at least two samples.

e ....,

•-•, ! . coli viable counts

Symbols:

! . fragil is viable

counts.
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growth occurred slighly earlier, reaching approximately 10

8

cells/ml

by 24 h (Fig. 15).
5.

Effect of inoculum size of E. coli on growth of B. fra-

gilis in mixed culture.

In order to determine the effect of the

initial inoculum size of E. coli on B. fragilis growth in the mixed
culture system, two different inoculum sizes, 2 x 10
10

1

cells/ml, were tested.

As shown in Fig. 16,

~-

3

cells/ml, and

fragilis growth_

in the mixed culture was not significantly altered when the inoculum
size was reduced from 10

5

(Fig. 16) to 2 x 10

ever, when initial levels of

3

or 10

1

cells/mi.

How-

!· coli were reduced to 10 l cells/ml,

viable numbers of B. fragilis obtained at 24 h were significantly
lower than that observed with the 10

3

or 10

5

cell inoculum of E.

££!!·

It is apparent from these observations that, under certain
conditions, growth of

~-

fragilis is markedly enhanced by the initial

coexistence of E. coli.
6.

Mechanism of the enhancement of B. fragilis growth by

E. coli in Bacto-peptone medium.

A variety of mechanisms might be

responsible for the enhancement of
mixed culture.

~·

fragilis growth by

These include the following:

in media used was too high to allow
tion of oxygen by

!·

~·

!· coli in a

a) Dissolved oxygen level

fragilis growth.

The utiliza-

coli during its growth reduced oxygen to a very

low level, allowing growth of

~·

fragilis; b) Preformed toxic sub-

stances might be present, or exposure of media to storage might cause
the production of toxic peroxides or superoxides.

E. coli could uti-

lize or alter toxic substances on its growth, and is capable of ridding
the media of toxic oxygen products by its catalase and superoxide dis-

,-)

Fig. 16.

Effect of~· coli inoculum size on the enhancement of
!· fragilis growth in Bacto-peptone medium.

.·";

2 x 10 3

"'

1

cells (A) or 10 cells (B) of ~· coli were inoculated
5
with 10 cells of B. fragilis to Bacto-peptone medium and
incubated under aerobic conditions at 37°C for 24 h.

"'

Viable

cell number was determined as described in Materials and
Methods.

Each point represents the mean of at least two

samples.

Symbols:

x-x, growth of!· fragilis alone, o-o,

growth of !· fragilis when in combination with an inoculum
1

cells of ~· coli/ml; Growth of ~· coli after inocula3
tion of 5 x 10 cells/ml ( • - • ), or 101 cells/ml (!-t)

of 10

with B. fragilis was also.
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mutase enzymes.

~·

fragilis could then initiate growth; c)

~·

coli

might produce and excrete vitamins or nutrients stimulatory to E. coli.
This (these) substance(s) might be some type of material already
defined as a growth factor

for~·

fragilis, or may be an as yet un-

identified stimulatory material(s).
To determine which of these mechanisms were actually involved in
E. coli induced enhancement of

!·

fragilis growth in mixed culture,

each of the possibilities was analyzed individually.
a.

Dissolved oxygen.

The dissolved oxygen level of variously

treated Bacto-peptone media and growth of B. fragilis in each are
shown in Table 10. The level of dissolved oxygen in media immediately
.
-6
after autoclaving was approximately 30 x 10
moles/1. B. fragilis
grew in this medium or in freshly autoclaved media that had been
placed immediately under anaerobic conditions and stored there before
use.

However, if media were stored aerobically, the dissolved oxygen

level increased to 67 x 10190 x 10-

6

6

moles/1 by 24 h and increased further to

moles/1 after 48 h.

ally or anaerobically

~· fragilis never grew either aerobic-

in peptone stored for 24 h or longer after

autoclaving.
The growth of

~·

coli in stored peptone medium reduced dissolved

oxygen to a level below that observed in freshly autoclaved medium.
After oxygen level was lowered
growth occurred.

by~·

coli, initiation of B. fragilis

It has been demonstrated (data not shown) that in

a mixed culture shaking under aerobic conditions,
grow.

~·

fragilis will not

In the same respect, vortexing freshly autoclaved peptone

diminished the amount

of~.

fragilis growth (Table 10).

The reduction
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TABLE 10.
Growth of B. fragilis and oxygen levelsa in Bacto-peptone
medium (5%) stored under various conditions
d

Conditio~

of

storage

Growth

c

(cells/ml)

8

Dissolved oxygen
at time of inoculation
(].lmoles/1)

None (Freshly
autoclaved)

5.5

X

10

Vortexed (2 min)

8.0

X

10

24 h under anaerobic
conditions (24°C)

4.9

X

10 9

10.2

24 h under aerobic
conditions

2.4

X

10 3

67.5

10

48 h under aerobic
conditions
24 h aerobically, then
24 h anaerobically

8.3

X

10

24 h aerobically, then
boiled 30 min.

3.6

X

10

a

b

c

d

6

30
187.5

192.5
2
6

10
47.5

Growth and oxygen levels are representative of at least 2 determinations.
Supplemented with 0.05% hemin and kept at 25°C during storage.
Media were inoculated immediately after the designated treatment
to a final concentration of 2.5 x 10 5 cells/ml of B. fragilis and
and incubated at 37°C for 24 h anaerobically.
Measured by a Clark type electrode immediately before inoculation.
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of dissolved oxygen, then, is vital to the growth of B. fragilis. However, this may not be the only action of

!· coli that enhances B. fra-

gilis growth.
If oxygen alone were responsible for inability of B. fragilis to
grow, stored peptone media, which was treated by procedures to lower
oxygen level without altering other parameters, ought to subsequently
allow growth of !· fragilis.

Media which was initially stored for 24

h under aerobic conditions, was subsequently placed under anaerobic
conditions for 24 h or boiled for 30 min before inoculation with B.
fragilis.

B. fragilis grew only slightly in stored media that was

boiled before inoculation, and actually lost viability in stored peptone placed under anaerobic conditions for 24 h before inoculation
(Table 10).

This would indicate that reduction of oxygen cannot com-

pletely account for enhancement of B. fragilis growth.

In confirma-

tion of these findings, other facultative microorganisms,

~·

vulgaris,

K. pneumonia and !· aureus, all known to rapidly reduce oxygen tension
in media, were grown in mixed culture with!· fragilis (Table 11).
S. aureus did not stimulate growth of the anaerobe.
garis and K. pneumoniae did enhance

!·

Although

~·

vul-

fragilis growth, enhancement

was not observed until 48 h, whereas enhancement by

!·

coli was observ-

ed at 24 h.
E. coli is apparently responsible for reducing oxygen level in
media, a requirement for growth of the!· fragilis.

However, this

mechanism is not alone sufficient to account for the optimal
gilis growth seen in mixed culture.
participating in this phenomenon.

!· fra-

Other mechanisms must also be
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TABLE 11.

Enhancement of ~· fragilis growth by
other organisms in 5% Bacto-peptonea

Organismb

Growth of B. fragilis
viable cell/ml at
48 h
24 h

E. coli

1.72 X 10

P. vulgaris

7.1 X 10 4

K. 2neumoniae

103

s.

NDC

aureus

7

6.0

X

10 8

4.9 X 10
1.9x 10

8
9

3 X 104

a Supplemented with 0.05% hemin
b Media were inoculated with 2 5 x 10 5
B. fragilis cells/ml, 3 x 10 5 cells/ml
of ~· xulgaris or K. 2neumoniae, or
3 x 10 cells/ml of S. aureus, and
incubated aerobically at 37° C. Growth
is representative of at least 2 determinations.
c ND = not done.
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b.
bitors.

Removal of toxic superoxide radicals or other growth inhiTo determine if removal of superoxide radicals would allow

growth of B. fragilis in peptone broth, superoxide dismutase (65
units activity/ml), prepared as described in Materials and Methods,
was added to stored peptone (Table 12). When superoxide dismutase was
not added, all B. fragilis lost viability by 24 h.

Addition of super-

oxide dismutase to the medium slowed the rate of viability loss,
although by 48 h complete loss in viability of B. fragilis was still
observed.
It is possible that !· coli is utilizing or removing toxic
substances in the stored peptone that are inhibitory to the growth of

!· fragilis.

To test this possibility, the stored peptone was treated

with activated charcoal, filter sterilized and then inoculated with

!·

fragilis.

The result of this study is shown in Table 13.

gilis grew in such a peptone medium to a level of 10

9

B. fra-

cells/ml indi-

eating that there are some toxic substances in stored peptone that can
be removed or altered by!· coli when in mixed culture.
c.

E. coli production of nutrients or vitamins that stimulate

the growth of B. fragilis.
internal components of

!·

To determine if preformed structures or
coli would stimulate growth of B. fragilis,

heat killed !· coli were inoculated along with!· fragilis to stored
peptone under anaerobic conditions.

As many as 10

were heat killed by boiling for 30 minutes.

8

cells of E. coli

Addition of the heat

killed E. coli to stored peptone did not stimulate the growth of

!·

fragilis under any experimental condition tested (data not showq).
Stored peptone was supplemented with hemin, menadione,

~onium
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TABLE 12
Effect of superoxide dismutase on the growth
of B. fragilis in 5% Bacto-peptone mediuma
Growth
viable cells/ml at
24 h
48 h

Medium
Stared peptone

c

10

Stored peptone+
65 units/ml SOD

3.0

Control (freshly
autoclaved peptone)

1.6x 10

X

10

10
2
9

10
1.7x 10

9

aSupplemented with 0.5% hemin.
5
bMedia were inoculated with 2.5 x 10 ~· fragilis
cells/ml and incubated anaerobically at 37° c.
Growth is representative of at least two determinations.
cStored aerobically for 24 h at 25°

c.
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TABLE 13.
Growth of

!· fragilis in Bacto-peptone mediuma (5%)
treated with activated charcoal

Treatment

Growth
viable cells/ml

10

None
Stored medium adsorbed with activated
charcoal

3.28

X

10 9

Control
(freshly autoclaved)

1.45

X

10

9

a

Supplemented with 0.05% hemin.

b

Media were inoculated with !· fragilis
to a final concentration of 2.5 x 105
cells/ml and incubated anaerobically at
37° C for 24 h. Growth is representative
of at least 2 determinations.
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sulfate, ferrous sulfate, and/or a vitamin mixture (Table 14).
~·

these substances are known to be stimulatory to
circumstances (Varel and Bryant, 1974).
enhance the growth

of~·

All of

fragilis under other

In no case did these materials

fragilis.

An experiment was devised to determine if !· coli produced subto~·

stances that were stimulatory
was supplemented with 0-5.0 ml

!·

fragilis.

coli spent medium, and the volumes

equilibrated to 10 ml with sterile saline.
with

~·

fragilis to 10

5

cells/ml.

medium allow optimal growth of
(Table 15).

~·

Stored medium (5.0 ml)

Tubes were then inoculated

Addition of 2 ml or more of spent
fragilis to 10

9

cells/ml by 24 h

This suggests that the spent medium contained material(s)

produced by!· coli capable of stimulating growth
dilution of toxins was not responsible for

~·

of~·

fragilis.

A

fragilis growth since

stored medium to which various amounts of sterile saline had been
added did not support growth

of~·

fragilis.

From the data presented above, it is likely that at least three
different mechanisms are jointly responsible for growth of
in mixed culture in stored peptone.

These are:

~·

fragilis

1) removal of dissolv-

ed oxygen, 2) removal or inactivation of toxic substances and 3) production of a factor(s) stimulatory to the growth
B.

of~·

fragilis.

Interaction of B. fragilis and E. coli when grown in mixed

culture in semi-synthetic medium.

The data presented in the preceed-

ing section strongly indicate that the stimulation of B. fragilis
growth by!· coli in mixed cultures is mediated, at least in part, by
a substance or substances accumulating in the medium as a result of

!· coli growth. To further characterize such substances it was thought
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TABLE 14
Growth of B. fragilis in Bacto-peptone ~edium
(Lot #540620) supplemented with various additives
Growth
viable cells/ml

Supplements
Hemin (0.05%)
Hemin + Menadione

10
(O.OOO~o)

10

Hemin + Cyanocobalamin (ng/ml)

10

5
25

10
10
10
10
10

so

100
500
Hemin + Ammonium sulfate (mM)

0.03
0.15
0.30
0.60
3.00
Hemin+ Menadione (0.0005%)
+ Cyanocobalamin (SOng)
+ Ammonium sulfate (0.3 mM)
+ Vitamin mix

10
10
10
10
10

3.5

X

10 2

5
aThe media were inoculated with 2.5 x 10 ~· fragilis
cells/ml and incubated at 37° C for 24 h anaerobically. Growth is representative of at least
two determinations.
/

(

\

)

"
i
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TABLE 15.
Growth of !· fragilis in stored Bacto-peptone medium
supplemented with various amounts of spent medium

Stored
peptone a

!· fragilis growthc

Spent
peptoneb

diluent
(H 0)
2

10

0

0

3.0

X

103

5

0

5

1.1

X

10

5

1

4

5.7

X

10

5

2

3

2.3

X

10 9

5

3

2

2.5

X

10

5

4

1

2.3

X

10

5

5

0

2.6

X

10

0

10

0

2.9

X

10 9

'
/

(viable cells/ml)

3
8

9
9
9

'i

a Stored atLroom temperature for 24 h under
'
aerobic co~~itions.
b

Spent by 24 h of E. coli growth and filter
sterilized before use.

c The media was inoculated with a 2.5 x 10 5
B. fragilis cells/ml and incubated under
anaerobic conditions for 48 h at 37° c.
Growth is representative of at least 2
determinations.
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that a synthetic or semi-synthetic medium was more preferred to complex
peptone media.

On the basis of several preliminary experiments, a

modification of the semi-synthetic medium of Roberts et al. (1955) was
selected and used throughout this investigation.

1.
E. coli.
--

Kinetic studies of enhancement of B. fragilis growth by

B. fragilis slowly lost viability when incubated alone in the

semi-synthetic medium, either aerobically or anaerobically (Fig. 17).
No initial rapid drop in!· fragilis viability, as that seen in certain
peptone media (iig. 13, 14), was observed in this medium.

This obser-

vation indicates that toxic substances that were shown to be present
in specific lots of peptone media are not present in the semi-synthetic medium.

Absence of toxic substances in this medium was further

confirmed by demonstrating that semi-synthetic medium would not inhibit !· fragilis growth using the agar diffusion method described below
(Fig. 18).

In contrast to the loss in viability of B. fragilis in

pure culture, !· fragilis, in mixed culture with E. coli, increased in
number from approximately 10
2.

5

cells/ml to 10

7

cells/ml in 48 h.

Enhancement of B. fragilis growth in mixed culture after

inhibition of E. coli by kanamycin.

To determine how much E. coli

growth was necessary to initiate the growth of!· fragilis,

!· coli

was inhibited by the addition of kanamycin (final concentration, 100
llg/ml) at various times' after inoculation of mixed cultures.

-,

When

kanamycin was added at 0 tf~ or 2 h, growth of B. fragilis did not
occur (Table 16).

In fact, a slight loss in viability was noted.

However, kanamycin added at 4 h did not prevent the subsequent enhancement of B. fragilis growth.

,

.:~

;

"'
Fig. 17.

Stimulation of B. fragilis growth by the growth of!· coli
in semi-synthetic medium.
!·

££!!,

Approximately 105 cells of !· fragilis

or the combination of both were inoculated to semi-

synthetic medium, and incubated at 37°C under aerobic conditions.
Viable cell number was determined as described in Materials and
Methods.

Each point represents the mean of at least two samples.

Symbols:

•-•,

~·

!· fragilis alone;

coli alone or mixed with!· fragilis; A-A,

e-e,

!· fragilis mixed with!· coli.
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·
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Fig. 18.

Lack of inhibition of B. fra g ilis growth on enriched
TSA by stored peptone or semi-synthe ti c medium.

The

surface of enriched TSA was spre ad with approx imately
6
10 cells

of~· fragilis and wells cut.

The wells

were f illed with 0.25 ml of (A and B) stored peptone,
(C and D) s emi-synthetic medium, or (E) hemin (control).

L

86

TABLE 16.
Effect of E. coli growtha on the growth of
B. fragilis in semi-synthetic medium
Time of supplementation
with kanamycinb (h)

None added

B. fragilis growthc
(cells/ml)

1.6x 10 7

0

1.0

X

10

2

8.0

X

10

4

1.7

X

10

5

4
7

a Broth was inoculated with 2.5 x 10 5 cells
each of !· fragilis and !· coli.
b

!·

coli growth was selectively halted at the
designated times by addition of kanamycin to
a final concentration of 100 ug/ml.

c Viable cell number of B. fragilis was determined after anaerobic incubation for 48 h
at 37° C.

~.·
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3.

As
J

Demonstration of the B. fragilis growth stimulatory

described above, B. fragilis growth was stimulated by

broth media.

~·

coli in

To confirm this finding, and to establish a rapid

method for qualitative determination of the presence of

!·

fragilis

growth stimulatory materials, a plate agar diffusion technique was
developed.

Wells were cut in TSA plates, !· fragilis seeded onto the

plate surfaces and the wells filled with

!· coli spent media.

After

seeded plates containing stored peptone or semi-synthetic medium were
incubated for 24 h at 37°C under anaerobic conditions, visual inspection of the plates revealed no stimulation of
19).

!· fragilis growth (Fig.

However, it was clearly demonstrated, as seen in Fig. 19, that

spent peptone and spent semi-synthetic medium did stimulate the
growth of
method.

!· fragilis, confirming results observed in the broth

This technique will be used to determine the ability of spent

media treated in various manners to retain the stimulatory ability.
C.

Some properties of the B. fragilis growth stimulatory

factor(s) produced by E. coli.

In order to further define some of the

properties of the stimulatory factors produced by

!· coli, spent semi-

synthetic medium was treated in a variety of manners and then assayed
for the capacity to stimulate
system.

!· fragilis growth in the plate assay

Some general properties of the stimulatory materials can be

seen in Table 17

a~d

effect of spent medium on

after various treatments observed in Fig. 20.

!· fragilis stimulation
The stimulatory materi-

al was found to be quite stable to heat, acid or alkali.

Treatment by

boiling for 30 min, or exposure to pH 2.0 or pH 12.0 for 30 min, did

89

..... .·

..

TABLE 17
Effect of various treatments on the B. fragilis
stimulatory activity of spent semi-synthetic medium

Fig. 19.

Stimulation of ~· fragilis growth by
and spent semi-synthetic medium.

!· ~

spent peptone

The surface of TSB was

spread with approximately 106 cells of ~· fragilis and
wells cut.

The wells were filled with 0.25 ml of (A) hemin

alone (control), (B) stored peptone medium, (C) spent peptone medium, (D) spent semi-synthetic medium, or (E)
semi-synthetic medium.

Treatment of
spent peptone

Stimulationa of
B. fragilis growth

None

+

Boiling ( 30 min)

+

Dialysis (against
distilled H o)
2
Acid (pH 2.0, 1 h)

+

Alkali (pH12.0, 1 h)

+

Cationic resin
(cl- charged)
Anionic resin
(H+ charged)
Ether extraction

+

aStimulation dete~ined on solid me~i~m.
Approximately 10 cells of ~· frag~l~s
were spread on the surface of either TSA
or enriched TSA. Wells were cut, and
treated spent medium placed in the wells.
Growth stimulation was defined as enhanced
growth around the wells

90

.....

Fig. 20.

..

"

Stimulation

of~·

fragilis growth by spent semi-synthetic

medium subjected to various treatments.

The surface of

TSA was spread with approximately 106 cells of~· fragilis.
Wells were cut and filled with 0.25 ml of test fluids.
Wells A and F contain hemin (control), well E contains semisynthetic medium (concentrated 20-fold), and well G contains
20-fold concentrated spent semi-synthetic medium.

The other

wells contain spent semi-synthetic medium concentrated
and treated by (B) boiling for 30 min., (C) acid (pH 2.0),
1 h (D) alkali (pH 12.0), 1 h, (H) dialyzed extensively
against distilled water, (I) exposure to cationic (Cl
resin, or (J) exposure to anionic (H+ charged) resin.

~ba

)
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not destroy capacity to stimulate

~·

fragilis growth.

The molecular

weight of the material appeared to be less than 10,000 since dialyzed
spent medium no longer stimulated

~·

fragilis.

Ether did not extract

the stimulatory materials, although it was removed by both cationic
and anionic exchange resins.

DISCUSSION
This investigation has provided some new and significant
information as to the role and the nature of microbial interactions
in the pathogenesis of intraperitoneal abscess formation.
~·

was shown that the combination of

First, it

fragilis and E. coli caused the

formation of large intra-abdominal abscesses in rats, although abscess
weight was not statistically different from that observed in infections induced by

!· coli alone.

Both

~·

fragilis and E. coli were

independently able to cause intraperitoneal abscess formation.
Second, an interaction between
strated for the

.
first

greatly enhanced by

!·

coli and

~·

fragilis was demon-

time in vitro; the growth of

!·

fragilis was

!· coli growth in certain peptone media and a

semi-synthetic medium.

In addition, the present study has clarified

two important questions pertaining to the susceptibility

of~·

fragilis

and!· coli to oxygen and low temperature.
I.

Susceptibility of B. fragilis and E. coli to oxygen and low temperature.
B. fragilis is a mesophilic (optimal growth temperature:

and obligately anaerobic organism.

37°C)

Since it was often necessary to

handle this organism in open air, ot-to store bacterial specimens for
-,

later processing, we initiallyrlnvestigated the effects of oxygen and
other storage conditions on the survival of this organism.

Although

it has been relatively well established that clinically
important anaerobic bacteria are tolerant to exposure to atmospheric
92
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oxygen (Bartlett et al., 1976; Loesche, 1968; Tally et al., 1975)
there is still controversy as to whether anaerobic bacteria can be
safely exposed to low temperature (Finegold et al., 1974; Dowell and
Hawkins, 1974; Holdeman and Moore, 1972).

We believe that preliminary

experiments investigating the effects of these parameters are essential for drawing valid conclusions from our
Unlike some of the strict anaerobes,

e~eriments.

!·

fragilis was found to

be quite oxygen tolerant, although no growth took place under aerobic
conditions (Fig. 2, 4, 5, 6).
oxygen in our strain of
particular isolate.

!·

This high degree of resistance to

fragilis does not seem to be unique to this

The data published from several other labora-

tories also indicate that

!·

fragilis is in general quite tolerant to

oxygen (Bartlett eta!., 1976; Loesche, 1969; Tally et al., 1975).
The biochemical basis of this unique oxygen tolerance of the anaerobe,

!· fragilis, has been recently elucidated.

Tally et al. (1977) and

others (Gregory et al., 1978) have demonstrated that low levels of
superoxide dismutase, the enzyme that converts toxic superoxide
radicals to a nontoxic form, can be found in B. fragilis.

More

detailed biochemical reactions involved in this detoxifying mechanism
are found in reviews by Fridovich (1975) and Halliwell (1978).

Most

strict anaerobes do not contain this enzyme and are rapidly rendered
nonviable by the action of
aerobic

environmen~.

superoxi~

radicals generated in the

~·

~

It is generally accepted practice in microbiology that cultures
stored for later processing are kept at low temperatures, most
commonly at 4°C.

However, whether one may store cultures containing
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strict anaerobes in a similar manner has been disputed for some time
among clinical microbiologists.

Some (Dowell and Hawkins, 1974;

Holdeman and twore, 1972) warned that specimens should not be exposed
to chilling since anaerobes are highly susceptible to low temperatures.
On the other hand, Finegold et al. (1974) recommended that these
specimens should be refrigerated to slow down the growth of coexistent facultative bacteria if the specimens could not be cultured
within 2 h.
Our data (Fig. 2-8) show that

!· fragilis was rapidly killed at

low temperature, both in vitro and in experimentally produced pus,
under most experimental conditions tested.

Other investigators

(Gorrill and McNeil, 1960; Hegarty and Weeks, 1940;

St~ange

and Dark,

1962) have also demonstrated the lethal effect of low temperature on
gram negative organisms.

Strange and Dark (1962) demonstrated that

chilling was lethal to Enterobacter aerogenes to varying degrees,
depending on the phase of growth, the diluent, and the concentration
of bacteria.

In 1972, Leder demonstrated that glycerol would protect

against lethality from cold shock by increasing osmotic pressure.

In

agreement with this finding, we have shown that increasing osmotic
pressure by the addition of CaC1

2

and sucrose (Table 2) could greatly

reduce the lethality normally observed after exposure to low temperature.

A leakage of endogenous constituents (Strange and Dark, 1962)

due to a precipitation (Ring, 1972) or crystallization (Leder, 1972)
of certain membrane lipids was thought to be responsible for the
lethality to

microorganisms.

Whether a

simi!~

mechanism may be

"\__; 1

responsible for the killing of B. fragilis remains to be determined.
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On the basis of the data obtained in our preliminary experiments, (a)
all cultures were" processed immediately after collection, or freshly
grown cultures were routinely used so that no prolonged storage perllrls
were required, and (b) experiments

involving~·

fragilis were per-

formed on the bench under aerobic conditions except that all anaerobes
were incubated under anaerobic conditions.
II.

In vivo and in vitro interaction of B. fragilis and E. coli.
Because the animal model devised in this study not only enabled

us to accurately control the type and number of bacteria to be
implanted into the peritoneal cavity, but also allowed the implanted
organisms to remain at the site of inoculation, we were able to evaluate the abscess forming ability of
cisely.

!· fragilis and!· coli more pre-

In addition, the foreign material in which the microorganisms

were impregnated roughly simulated fecal material, both in consistency
and in the fact that it contained a ground meat mixed with cellulose.
Since our model employed a defined artificial fecal material free from
unidentified enteric bacteria and their products, we believe that it
was better suited for this type of study than any other models previously reported.
Several investigators (Meleney, 1932; Rite et al., 1949; Lorber
and Swenson, 1975; Stone et al., 1975; DeHaan et al., 1974; Finegold
and Rosenblatt, 1973) have suggested that a "synergistic" mechanism
between aerobic and anaerobic microorganisms might be involved in the
development of anaerobic infections.

However, in most instances,

evidence presented in support of their conclusion is far from con~J
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vincing.

Furthermore, the term "microbial synergy" has been used

indiscriminantly, and often incorrectly.

Synergism, in the strict

sense, refers to a bilateral relationship in which both populations
benefit from each other (Frederickson, 1977).

In most cases, (Lorber

and Swenson, 1975; Stone et al., 1975; DeHaan et al., 1974; Finegold
and Rosenblatt, 1973), the involvement of microbial synergy in the
formation of anaerobic abscess was suggested only on the basis of the
fact that high percentages of specimens collected from anaerobic
infections contain a mixed flora of

aerob~c

and anaerobic bacteria.

Considering the complex nature of microbial flora contaminating wounds
or the abdominal cavity, it is not too surprising to find a variety of
microorganisms, both aerobic and anaerobic, in the infected lesions.
There has been no convincing evidence presented in prior studies
indicating that both aerobic and anaerobic bacteria synergistically
participate in the development of such infections.
There have been, however, a few investigations that have provided some experimental evidence to support this theory of synergism.
Altemeier (1942) performed some rather preliminary studies on the
pathogenicity of mixed cultures in guinea pigs.

He reported that a

mixed flora of facultative aerobes and anaerobic bacteria was isolated
from 96/100 patients with perforated appendix.

Subcutaneous implan-

tation of pure cultures of the organisms into guinea pigs failed to
produce gangrenous lesions.

However, when certain combinations of

these organisms were implanted, animals developed extensive cellulitis
accompanied by gangrene.

Somewhat similar findings were reported by
)

other investigators (Meleney, 1932; Hite et:jal., 1949).

More recently,
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an apparently true synergism between

!· coli and !· fragilis in the

formation of intraperitoneal abscess in rats was reported by Onderdonk
et al. (1975).
enterococcus,
abscesses.

In their study, no animals implanted with E. coli,

!· fragilis or F. varium alone developed intra-abdominal

Likewise, the combination of either anaerobes alone

fragilis and!· varium), or aerobes alone
did not cause abscesses.

(!.

(!.

coli and enterococcus),

However, 89-100% of animals receiving com-

binations of one aerobe and one anaerobe developed abscesses by 7 days.
The specific combination of E. coli
gilis (2.5 x 10

7

(1~3

x 10

7 cells/ml) and B. fra-

cells/ml) produced intra-abdominal abscesses in 100%

of the animals.
Our results (Tables 4, 5, Fig. 10) agree with
Onderdonk et al. (1975) in that the combination of

the~conclusion

of

!· fragilis and

!· coli resulted in the formation of large intra-abdominal abscesses.
However, in contrast to their findings, we have found both

!·

!· coli and

fragilis to be independently capable of causing intraperitoneal

abscesses to

form in rats (Table 4, 5, Fig. 10).

Our results are

consistent with the observations of others that B. fragilis alone can
cause intra-abdominal abscesses in experimental animals (Hill et al.,
1974; McConville et al., 1976; Renz et al., 1975; Walker and Wilkins,
1976).

In our animal model, it was possible to produce intra-abdominal

abscesses with E. coli alone (Table 4, 6, Fig. 10).

T~ our
~r

knowledge

this is the first study demonstrating intraperitoneal abscess formation by a gram negative facultative rod.

Our finding is difficult to

reconcile with the data reported by Onderdonk et al. (1975), who
showed that

presenc~f

both E. coli and B. fragilis was necessary for
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the abscess formation.

However, Onderdonk et al. (1975) and others

(Nichols et al., 1978), have used sterile cecal contents (which contain a multitude of bacterial endproducts, lysed bacteria, and bacterial components), as well as barium sulfate, to help initiate and
potentiate abscess formation.

The problems associated with this use

of a complex inoculum and unnatural additives was avoided by our use
of an artificial fecal material.

In addition, Onderdonk et al. (1975)

used rat strains of B. fragilis and

!·

coli, whereas organisms used

in this investigation were human isolates from actual intraperitoneal
abscesses.

The strain of rats used in each study also differed.

The elucidation of types of microorganisms actually involved in
pathogenesis is a very significant consideration when determining
appropriate antibiotic therapy for these infections.

Currently, there

are two major approaches for the treatment of anaerobic abscesses.
First, if truly synergistic interaction is involved in abscess formation as shown by Onderdonk et al. (1975), treatment of either component alone should prevent abscess formation.

In fact, some investi-

gators (Polk, 1977; Stone et al., 1975) suggested that if only the
aerobic component were treated, anaerobic infections could be prevented.

Polk (1977) observed that failure to treat mixed aerobic-

anaerobic infections with cephaloridine resulted in a fourfold rise
in infection rate.

Stone et al. (1975)Jperformed a study on the
\_/-

effectiveness of clindamycin or cephaloridine on patients with infections resulting from abdominal disease, surgery or trauma.
cephalothin, which is relatively ineffective against
resulted in an infection rate of 3%.

~·

Use of

fragilis

These data suggest that treat-
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ment of the aerobic component of the mixed flora will be sufficient to
reduce rate of infection.

In contrast o this, several investigators

(Busch et al., 1976; Griffith et al., 1977; Klastersky and Husson,

1977; Weinstein et al., 1974) have emphasized the need for treatment
of both aerobic and anaerobic flora or a mixed infection.

Using a

model of abdominal sepsis developed earlier, Weinstein et al. (1974)
studied the efficacy of gentamicin alone, clindamycin alone, or the
combination of both antibiotics in the treatment of anaerobic infections.

He demonstrated that gentamicin, effective against the aerobic

flora, greatly reduced peritonitis, but not the rate of abscess formation, whereas clindamycin, affecting

!·

fragilis, greatly reduced the

rate of abscess formation, but not peritonitis.

Both antibiotics

were necessary for optimal therapy of a mixed infection.

Fass et al.

(1978) demonstrated the efficacy and safety of this combination in
treatment of clinical anaerobic infections.

Other investigators

(Busch et al., 1976; Griffith et al., 1977; Klastersky and Husson,

1977) studied various combinations of therapy for the treatment of
anaerobic infections and sugge)ted that both aerobic and anaerobic
ganisms should be treated since too little is known about the
-)

thogenesis of such mixed infections to do

otherwise~~-

.The results

;Jf our animal studies demonstrate experimentally that both aerobic and

~anaerobic

flora should be treated in a mixed infection.

Since both

I

B. fragilis and

~·

coli were individually able to cause intraperitoneal

abscesses, it would be necessary to treat both organisms to completely
prevent abscesses from forming.
Bowel spillage, resulting from disease, trauma, or abdominal
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surgery, often results in intra-abdominal abscess formation.

However,

depending on the conditions of spillage, infection may not occur, a
peritonitis may develop, only an abscess might form, or a peritonitis
followed by abscess might be seen.

Until now, there has been little

experimental data to explain the factors which determine the outcome
of spillage of intestinal contents.

Using our animal model, the effect

of various factors on such infections was

examined in an attempt to

more clearly understand the actual role of B. fragilis and E. coli in
pathogenesis of intra-abdominal sepsis.
It is possible that no infection will result from spillage of
colonic contents into the peritoneal cavity.
fluid,

=:~~ of organisms small,

If the material is quite

the contaminating material will

rapidly ~iffuse throughout the peritoneal cavity and be effectively
phagocytized by the body's defense mechanisms.

We have shown that if

microorganisms are not held within a localized area by the some type
of solid material or semi-solid material, abscess formation does not
occur (Fig. 9).

In no

c~e

did direct inoculation of!· fragilis

alone, or the combination of B. fragilis and

!·

coli, into the peri-

toneal cavity result in intraperitoneal abscesses in rats.

E. coli

was rapidly phagocytized and could not be isolated from the abdominal
cavity by 3 days, whereas !· fragilis could still be isolated on day
15 from the abdomen (data not shown).

Although!· fragilis has been

shown to be readily engulfed and killed by rabbit polymorphonuclear
leukocytes in vitro (Casciato et al., 1975; Bjornson and Hill, 1973),
the chemotactic activity of

!·

fragilis endotoxin for phagocytic cells

appeared to be greatly reduced when compared to classical gram nega-
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tive endotoxins (Sveen, 1977).

!· fragilis lipopolysaccharide did

generate a leukocyte chemotactic factor (Sveen, 1978) even though
phagocytic cells did not appear to be effectively mobilized in the
B. fragilis infection.
Recently, a polysaccharide capsule has been discovered surrounding

!· fragilis subsp. fragilis (Kasper and Seiler, 1975) and has been

implicated in the pathogenesis of this organism.

Kasper et al. (1977)

demonstrated that all strains of subsp. fragilis possessed this polysaccharide, whereas other subspecies of B. fragilis did not have the
capsule.

Rowley (1971) has suggested that the thickness of a bacterial

capsule is a major factor in determining virulence.

Onderdonk et al.

(1977) showed that encapsulated strains of !· fragilis usually caused
I

intraperito eal abscess in rats whereas unencapsulated strains usually
did not i duce abscess.

In their model, capsular material alone

actually i du ed abscess formation.

It was also shown (Onderdonk et

al., 1978) that encapsulated strains of!· fragilis adhered to rat
peritoneal ep~thelium better than unencapsulated strains, suggesting a
role in virulence 6f the organism.

Contrary to this finding that only

subspecies fragilis possesses a capsule, Babb and Cummins (1978) has
shown that three of the other four subspecies, vulgatus, thetaiotaomicron and ovatus, also possess capsular material.

Consequently, the

role of this capsule in the pathogenesis of B. fragilis still remains
unclear.
If the number of certain bacteria, especially

!· coli, spilled

during trauma is high, the risk of severe peritonitis exists.

The

problem arises from the fact that E. coli contains a classical endo-
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toxin and is normally found in levels of 10 8 to 10
of colonic contents (Attebery et al., 1971).
gilis outnumbers

10

bacteria per g

In fact,

only~-

!· coli as normal flora of the human colon.

fraPeri-

tonitis is usually induced by the classical endotoxin of facultative
gram negative bacteria.

It is known to elicit fever, the Shwartzman

reaction, disseminated intravascular coagulation (DIC), and vascular
collapse in humans.
gilis.

This does not appear to be the case for

~·

fra-

This may be because the lipopolysaccharide structure of B.

fragilis is atypical when compared to that of facultative forms in
that heptose and 3-keto-2-deoxyoctonate are absent (Hofstad and
Kristofferson, 1970). Possibly due to this difference, DIC has not
~
been observed in most clinical ~· fragilis infections (Yoshikawa et
~~

al., 1974).

In o

animal model of abscess infection, peritonitis
as many as 10

has been notably absent w

placed into the peritoneal cavity of rats.

10

B. fragilis cells were
In contrast to this, 10

8

cells of E. coli, with its classical endotoxin, resulted in a 50%
lethality in rats.

Various in vivo

an~ in vitro assays, such as

mouse lethality, chick embryo lethality, rabbit biphasicfever

respons~

Shwartzman reaction and reactivity in the Limulus assay have all been
used to demonstrate the low toxicity of
per, 1976; Sveen and Milner, 1977).

~-

fragilis endotoxin (Kas-

No matter how the endotoxin was

extracted (the phenol-water, trichloroacetic ethylenediamine tetraacetic acid, or liquid phenol-chloroform petroleum ether method),
endotoxic activity as measured by skin inflammation in rabbits, was
low (Hofstad et al., 1977).
part, the inability of

~·

This lack of toxicity may explain, in

fragilis to induce the peritonitis that is
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so commonly associated with infections caused by other gram negative
rods.
Whether or not peritonitis results from spillage, abscess formation will most likely occur if organisms have been localized by solid
or semi-solid components of intestinal material.

In our animal model,

the addition of artificial fecal material or blood clots to the bacterial inoculum resulted in abscess formation (Table 4, 5, 6, 7, Fig.
10, 12).

It appears that these materials prevent rapid dissemination

of bacteria through the peritoneal cavity, while allowing inoculated
bacteria to grow in situ.

Other investigators have also demonstrated

the necessity or potentiating effect of various substances on ability
of the organisms to cause abscesses.

These substances included feces,

(Deysine et al., 1967) cecal contents and barium sulfate, (Onderdonk
et al., 1975), mucin (Hill et al., 1974) or semi-solid agar (Walker
and Wilkins, 1976).
The body responds to such a localized contamination by surrounding and walling off the foreign material with sticky omentum.

One

such factor which might contribute to the walling off process is the
enzyme heparinase.

In a report in 1961, Gesner and Jenkin described

a heparinase produced'by certain strains of Bacteroides.

Many re-

ports (Bodner et al., 197 · Felner and Dowell, 1971; LeFrock et al.,
1976; Nastro and Finegold, 197
associated with human B.

have described thrombophlebitis

fragilis~lnfections.

suggested as responsible for this

ccurrence.

A heparinase has been
Such an enzyme would

interfere with normal homeostatic mechanisms i~olved in preventing
clot formation.

It would tend to allow clots to form, resulting in a
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dissemination of disease and possibly phlebitis.
point, production of a heparinase
been demonstrated.

by~·

We have found that

However, to this

fragilis in vivo has never
when~·

fragilis was implanted

into the peritoneal cavity of rats, microthrombi formed by 24 h
around the area of implantation (data not shown).

Control animals

implanted with E. coli did not form microthrombi.

These preliminary

data suggest that heparinase may indeed be formed.

Carrizosa et al.

(1977) has demonstrated that in a rabbit model of experimental endocarditis produced by a nonheparinase producing
vulgatus, phlebitis did not occur.

~·

fragilis subsp.

Although vegetations on the heart

appeared fragile and likely to disseminate, emboli were not found.
The severity of the abscess, and abscess size, are undoubtedly
determined by a variety of factors such as inoculum size, inherent
pathogenic potential of each organism and enhanced pathogenicity due
to microbial interactions.

Surprisingly, size of abscess formed was

not necessarily due to number of bacteria present in the contaminating
material.

Infection with

~·

uniformly resulted in small
10

6

fragilis alone in our animal model
absce~s,

organisms or 10,000 time larger

whether the inoculum size was
able 5).

abscess caused by E. coli remained large
was 10

5

or 10

tonitis.

7

Likewise, the size of

whether the inoculum size

cells, at which point animal

began to die from peri-

A most important observation was that extremely large

intraperitoneal abscesses were formed even when as low as 10 cells of
B. fragilis and 10 cells of

!· coli were impregnated into artificial

fecal material and implanted into the peritoneal cavities of rats
(Table 7).

This would, in part, explain the relative ineffectiveness
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of prophylactic antibiotics in preventing the development of abscess
infections following colonic surgery.

It has been shown (Clark et al.,

1977) that preoperative antibiotics only reduce the level of intestinal bacteria to 10

3

organisms/g of colonic contents.

Undoubtedly,

reducing the number of bacteria in spillage material will reduce
chances of infection, especially in terms of peritonitis.

However,

the number of bacteria remaining are more than sufficient to initiate
abscess formation, especially if

bo~h

aerobic and anaerobic flora

are allowed to interact.
We have described above some of the factors which probably
determine the outcome of spillage of

!· fragilis and E. coli.

c~lonic

co

ents containing

However, the actual mech nisms of interac-

tion between aerobic and anaerobic bacteria in absce ses and pathogenic factors elaborated there, are not known.

Since

I

was not

clear from our data (Table 4, Fig. 10) whether a synergistic interaction actually occurred between B. fragilis and

!· coli during

abscess formation, possible mechanisms by which these two organisms
might interact were investigated in vitro.
which B. fragilis and

One such mechanism by

!· coli might interact is the production by

one or both organisms of substances that are stimulatOfY to the growth
of the other.

To test this possibility, the in vitro growth of these

organisms in mixed culture was examined.
The data obtained from in vitro experiments clearly indicates
that a unilateral stimulation of

!· fragilis is occurring. When B.

fragilis was inoculated alone in certain media, it would not grow
(Fig. 13, 14, 17).

However, when cultured together, E. coli was found
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to stimulate the growth
the

~·

of~·

fragilis (Fig. 13, 14, 17).

coli inoculum required for stimulation of

reduced to as low as 10

1

cells/ml (Fig. 16).

~·

In fact,

fragilis could be

As discussed above, this

finding is significant in that even low numbers of

~·

coli might be

sufficient to cause mixed anaerobic infection.
The stimulation of

~·

fragilis growth by

~-

coli could be demon-

strated in two carefully selected growth media; stored Bacto-peptone
(Fig. 13, 14, 16) and semi-synthetic (Fig. 17) medium.
initial growth of

~-

In both media,

coli appears to be essential for subsequent growth

of B. fragilis.
Data obtained from the in vitro study appears to indicate that
at least three different mechanisms are involved in the stimulation of
B. fragilis growth by

coli.

~-

from the media by growth of

~-

1.

Dissolved oxygen might be removed

coli.

This reduction in oxygen level

is necessary before growth of the anaerobe,!· fragilis,can be initiated.

2.

Substances that are toxic or inhibitory to B. fragilis

might be present in the media.

If E. coli could metabolize or alter

---

these substances to a nontoxic form,
grow.

3.

growth.

~-

fragilis might be able to

!· fragilis might require some unknown factor(s) for its
It is possible that on growth of

~· ~,

these stimulatory

factors are derived from breakdown products of media components, or
are formed by E. coli de novo.

Each of the above possibilities will

be discussed below.
When 10

5

cells of

~·

coli were inoculated in Bacto-peptone media

and incubated aerobically at 37°C, the oxyge
9.1 to a minimum of 1.03

~moles/!

level was reduced from

within a 2 h time period (Fig. 13) •

•
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During this time,

!· fragilis continually lost viability. We have

shown that if E. coli was selectively inhibited by an antibiotic
during the first few hours of growth (Fig. 16),
not initiated.

!· fragilis growth was

This indicates that high levels of dissolved oxygen

might indeed be partially responsible for the inability of B. fragilis
to grow in such a medium.

This view is further supported by the

facts that stored boiled peptone partially allowed the growth of

!·

fragilis (Table 10) and that the introduction of oxygen to peptone by
vortexing rendered such a medium unsuitable for B. fragilis growth
(Table 10).

It is quite probable that the rapid scavenging of oxygen

by E. coli would modify physiologic conditions of infected sites,
creating an environment more conducive to the growth of B. fragilis.
However, the elimination of oxygen is not alone sufficient to account
for the observed stimulation of B. fragilis growth in vitro, since
(a) reduction in oxygen level in stored peptone by anaerobic incubation (Table 10) did not allow B. fragilis growth or (b) in spite of
the relatively high level of dissolved oxygen in other stored peptones (Table 8), B. fragilis was able to grow under certain conditions.

In addition, other facultative microorganisms that also

rapidly reduce oxygen level varied in their ability to enhance

!·

fragilis growth (Table 11).
Substances toxic to B. fragilis might be present in the stored
peptone.

When the medium was adsorbed with activated charcoal to

nonspecifically remove certain substances, and then inoculated with
~·

fragilis, slight growth occurred (Tabie

(1978) recently demonstrated that a

13). Carlsson et al.

va~iety o)fanaerobic broth media,
.

~
~

.
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including Brain Heart infusion (BBL), Trypticase soy broth (BBL), and
thioglycollate medium (Difco), accumulated hydrogen peroxide and superoxide radicals on storage under aerobic condit.ions.

Since B. fragilis

contains little or no catalase (Flen and Rosenblatt, 1976) or superoxide dismutase (Tally et al., 1977), the accumulation of such toxic
substances is certainly detrimental to the survival and growth of B.
fragilis.

However, the data presented in Table 12, which demonstrated

that superoxide dismutase had little effect. render this possibility
less likely, although it is still possible that toxic substances
other than superoxide radicals are metabolized or destroyed by coexistent E. coli.
Growth of B. fragilis might be stimulated by substances released
by

!·

the

coli.

!·

If the stimulatory substances were cellular components of

coli, addition of high concentrations of lysed cells should

enhance growth of
as 10

8

!·

fragilis.

Washed E. coli cells, as concentrated

cells/ml, were lysed by various treatments.

lysates, to

Addition of these

!· fragilis cultures under anaerobic conditions did not

stimulate its growth (data not shown).

This indicates that enhance-

ment of B. fragilis growth was not due to structural components of
E. coli.
Materials, stimulatory to B. fragilis growth, might be actively
produced and excreted by

!·

~into

the mediunh

We showed (Fig. 15,

/~/

17) that if E.

~

in a mixed culture was selective!

early stages (less than 2 h), growth of

!·

inhibited at

fragilis wo ld not occur.

It appears that the accumulation of a threshhold level of stimulatory
material is necessary to trigger B. fragilis growth, and that this
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level is achieved before 2 h of growth (Fig. 16).
It is significant to note that the initial presence of only
small numbers of E. coli (Fig. 17) is sufficie.nt to produce this
substance, and that such substances are produced only by certain
other enterobacteriaceae, but not by Staphylococcus aureus (Table
11).

Vitamins or nutrients produced by one organism have been shown

to stimulate another microorganism in various mixed culture interactions.
Bacillus

In the mutualistic interaction between Proteus vulgaris and
~.

biotin produced by

!·

vulgaris stimulated B.

myxa and niacin produced by B. polymyxa stimulated
et al., 1968).

Another study

demonstrated~·

!·

~-

vulgaris (Yeoh

cerevisiae stimulation

of a riboflavin requiring Lactobacillus casei (Megee et al., 1972).
B. melaninogenicus was shown (MacDonald et al., 1963) to be essential
for the pathogenicity of mixed cultures of organisms isolated from
periodontal disease.

However, another microorganism capable of

supplying it with required vitamin K was also necessary.
environment where

The micro-

!· fragilis is normally found (either in the intes-

tine or other infected sites) or the organisms with which they are
associated, may be capable of providing this organism with essential
growth stimulatory compounds.

Vitamins, such as vitamifi K, breakdown

products of blood, such as hemin, (Varel and Bryant, 1974; Sperry et
al., 1971), amino acids (methionine may substitute for the cyanocobalamin requirement,

Bryant, 1974),

man and Bryant, 1964) are known

~~des

and ammonia (Pitt-

~h stimul~~mpounds. If!·

coli could provide these substances, B. fragilis growth might be
initiated.

However, the data obtained from the present study seem to
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indicate that stimulatory compounds produced by

!· coli are not hemin,

vitamin K, ammonia, or amino acids, since no stimulation of

!· fragilis

in stored peptone medium has been observed by .the addition of these
substances (Table 14).
Iron is known to be a virulence factor for most microorganisms
(Calver et al., 1976; Wheeler and Hanks, 1965; Weinberg, 1974; Weinberg, 1978).

Hill demonstrated that iron-containing compounds such as

blood and hemoglobin enhanced the infection caused by mixed cultures of
B. fragilis and Peptostreptococcus anaerobius, and that the infection
enhancing effect could be duplicated by ferric ammonium citrate.

Our

data (Fig. 12) show that a plasma clot impregnated with B. fragilis or
E. coli and implanted into the peritoneal cavity of rats will not induce abscess formation.

However, a blood clot containing the same

organisms encapsulated and begins to form an abscess by 2 days.

In

contrast to this finding, Bornside and Cohn (1968) cquld find no
enhancement of virulence when hemoglobin as added to inocula of nonsporing anaerobic bacteria.
The human body normally prevents bacterial use of iron by the
production of iron-binding compounds such as lactoferrin and transferrin (Bornside and Cohn, 1968; Weinstein, 1978).

In spite of this

host mechanism to deny iron to bacterial invaders, some bacteria,
such as Salmonella typhimurium

strains of

(~,,~ty:l97:i)

and certain

!· coli (Payne and Finkelstein, 1977) have the capacity

to retrieve iron from the iron-lactoferrin complexes by the use of
siderophores (Wilkins and Lankford, 1970).
produced by

In fact, the siderophores

!· coli were able to assist other microorganisms in
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acquiring needed iron.

~·

coli might be performing this function

when in mixed infections with B. fragilis, although this possibility
was not investigated.
Another mechanism by which
for the growth of

~·

~·

coli might help prepare the area

fragilis is by its production of SOD.

As

dis-

cussed earlier, this is one of the means by which facultative organisms protect themselves from byproducts of oxygen metabolism, such
as superoxide radicals.
conditions.
formed,

If

~·

coli destroys these toxic radicals as they are

!· fragilis might be protected from their lethal effects and
Once initiated, the growth of !· fragilis, as

be allowed to grow.
well as

!· fragilis is normally killed under aerobic

!·

coli growth, would act to keep the area in a reduced state.

We have demonstrated that the stimulatory substances accumulated
in spent media are dialyzable (data not shown) and quite stable (Table
17).

By means of an agar diffusion method, it was further demon-

strated that these compounds are able to withstand heat (121°C for 15
min) and treatment to acid and alkaline conditions {Table 17).
stimulatory material produced by
(Table 17, Fig.

20~,

It was removed by

The

!· coli was not ether extractable,

and therefore, probably not lipid in composition.

oth anionic and cationic exchange resins (Table 17,

Fig. 20), implying that the material contains both positive and negative charges.

Further

tudies must be performed before any conclu-

sions concerning the exact nature of this (these) stimulatory
material(s) can be made.

The spent semi-synthetic medium should be

treated with enzymes that selectively destroy certain bacterial components, such as proteins, sugars, or nucleic acids to further identify
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the general composition of the material.

Extraction procedures could

then be used to concentrate and purify the stimulatory compounds.

In

addition, fractionation procedures would then be used to separate
actual components participating in the stimulation phenomenon. Various
electrophoretic and chromatographic techniques would then be employed
to assist in the identification of these materials.
From our data (Table 17), it is unlikely that the stimulatory
compounds are proteinaceous in nature, although certain extracellular
enzyme proteins such as SOD or iron chelating proteins elaborated by
one organism may stimulate the growth of bacteria deficient in such
proteins (Luckey et al., 1972; Payne and Finkelstein, 1978).

More

extensive discussions on these aspects of microbial interactions in
the pathogenesis of infectious agents are found elsewhere in this
section.
The outcome of microbial entry into the peritoneal cavity will
be determined by type and
number of microorganism
host defense mechanis
number of bacteria,
are introduced, seve

se of each organism spilled.

When the

is small, they may be rapidly killed by the
and no serious infections occur.

When a large

specially E. coli or other facultative anaerobes
peritonitis usually develops.

!·

fragilis,

even in high numbers, does not cause severe peritonitis, for still
undetermined reasons.

When, however,

!·

fragilis and E. coli are

introduced into the peritoneal cavity together with solid or semisolid intestinal contents, the organisms may survive and multiply
in the localized area which is surrounded by the omentum.

It appears

that the initial growth of E. coli may eventually render the area
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suitable to the growth of

!· fragilis by (a) removing available oxygen,

thereby lowering the overall oxidation reduction potential, (b) metabolizing oralteringmaterials, such as superoxide radicals, that are
toxic to the anaerobes, and/or (c) providing

!·

fragilis with sub-

stances required to, or stimulatory for, the growth of the anaerobe.
Once B. fragilis begins to grow, it may excrete various extracellular
enzymes.

Heparinase, presumably produced by B. fragilis, could assist

in this process by causing clot formation and resultant occlusion of
capillaries.

The infection thus becomes a rather closed system, fur-

ther protecting B. fragilis from dissolved oxygen in blood.
produced by

Enzymes

!· fragilis, during its growth, such hyaluronidase,

collagenase, protease, or lipase, could conceivably then destroy host
During this process, bacterial cell

tissue and extend the infection.
I

components and tissue damage cofld elicit the inflammatory reaction,
attract numerous phagocytic
abdominal abscess

~ls,

formatio~

~

and eventually result in intra-

SUMMARY

The interactions between Bpcteroides fragilis and Escherichia
coli were investigated

in~,and

in vitro.

It was shown that both

!· fragilis and !· coli /could independently produce intra-abdominal
abscesses in rats, provided that bacteria were implanted together
with simulated fecal

mat~l.

In this study, no strong evidence was

obtained which indicates that a synergistic interaction between
obligate and facultative anaerobes plays an important role in intraabdominal abscess formation.

The formation of intraperitoneal

abscesses was found to be influenced by several factors, such as the
nature of materials in which organisms were impregnated, type of
bacteria used, and the inherent pathogenicity of each organism.

The

presence of solid or semi-solid material was found to be necessary for
the induction of intra-abdominal abscesses.

If properly inoculated,

even low numbers of bacteria were able to produce abscesses.

The

number of bacteria inoculated did not affect the ultimate weight of
the abscess.
(>

However, if too high a number of

!· coli was inoculated

10 8 microorganisms) death from peritonitis invariably resulted.

In

contrast to this, no animals died from peritonitis even when very
large doses of B. fragilis were used (10
When

10

microorganisms).

!· fragilis and !· coli were incubated together in media

that would not allow the growth of B. fragilis, growth of the anaerobe
was stimulated.
of

Under our experimental conditions, approximately 2 h

!· coli growth was required before an increase in viable number of
114

'1\

115

I

~·

fragilis was observed.

Other {nteric organisms, such as Proteus

vulgaris and Klebsiella pneumoniae~ also found to enhance the
growth of!· fragilis, although Staphylococcus aureus would not.

At

least three mechanisms appear to be responsible for the stimulation
of B. fragilis growth by!· coli:

1.

Dissolved oxygen is removed

from the media by E. coli, lowering the overall oxidation-reduction
potential.

2.

fied by E. coli.

Substances that are toxic to B. fragilis are detoxi3.

!· coli provides some as yet unidentified com-

pound(s) required for, or stimulatory to, the growth of!· fragilis.
The stimulatory compound(s) accumulated in media by the growth of

!· coli was dialyzable and quite stable to heat (121°C for 15 min)
or mild acid and alkali treatments.

It was not extractable by ether,

but was removed by both anionic and cationic resins.

Based on the

data obtained in this investigation and those reported in the literature, a possible mechanism of anaerobic intra-abdominal abscess
formation was proposed.
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